Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3036185	maksa-2-is	U/l (u/l)	913	1034	0.00%
3036185	afosmaksa2	U/l (u/l)	532	604	0.17%
3036185	s-afmaks2	U/l (u/l)	180	205	0.00%
3036185	afosmaksa2	— (—)	177	189	100.00%	Distribution not available
3036185	s-maksa-2-isoentsyymi	U/l (u/l)	164	177	0.00%
3036185	s-maksa2	U/l (u/l)	123	132	0.00%
3036185	s-maksa-2	U/l (u/l)	99	110	0.00%
3036185	maksa-2-isoentsyymi	U/l (u/l)	77	79	0.00%
3036185	s-afos2ma	U/l (u/l)	67	76	0.00%
3036185	maksa-2-is	— (—)	63	71	100.00%	Distribution not available
3036185	afosmaks2	U/l (u/l)	56	68	0.00%
3036185	s-maksa-2-isoentsyymi	— (—)	24	27	100.00%	Distribution not available
3036185	maksa-2-ls	U/l (u/l)	18	22	0.00%
3036185	s-maksa-2	— (—)	12	12	100.00%	Distribution not available
3036185	s-maksa2	— (—)	11	11	100.00%	Distribution not available
3036185	s-maksa-2-isoentsyymi	U/L (u/l)	11	11	0.00%	Distribution not available
3036185	maksa-2-isoentsyymi	— (—)	6	6	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Diseases of liver

414

810

5.21

198.88

1.2

1.1

33.62

23.77

u/l

2.18

368

727

Care involving dialysis

172

122

14.79

190.36

1.3

1.1

27.58

29.32

u/l

0.08

166

109

Chronic kidney disease

374

669

5.48

187.57

1.2

1.1

34.08

24.87

u/l

1.50

352

570

Abnormal findings on examination of blood, without diagnosis

462

986

4.30

170.98

1.2

1.1

26.02

25.30

u/l

0.09

427

861

Dialysis, with operation codes

204

230

9.17

165.62

1.2

1.1

35.34

25.01

u/l

1.06

197

206

Renal failure

465

957

4.19

163.57

1.2

1.1

36.21

24.26

u/l

2.50

432

817

ILD medications: immunosuppressive drugs

526

1342

3.58

151.92

1.2

1.1

24.55

20.92

u/l

0.62

497

1169

All chronic kidney diseases

488

1020

3.86

150.54

1.2

1.1

33.85

20.60

u/l

3.44

455

879

Nephropathy related operations

194

239

8.39

146.77

1.2

1.1

36.99

27.31

u/l

0.91

187

213

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

723

1624

3.02

146.55

1.2

1.1

33.01

19.27

u/l

5.06

657

1433

Anaemias

203

122

10.80

145.88

1.3

1.2

33.98

10.72

u/l

2.96

186

112

Other diseases of liver

243

413

6.02

136.35

1.2

1.1

29.72

22.48

u/l

1.20

212

372

GASTRO-related operations

434

490

4.47

134.65

1.2

1.1

21.72

14.21

u/l

1.88

395

406

Any gastric operation

434

490

4.47

134.65

1.2

1.1

21.72

14.21

u/l

1.88

395

406

Autoimmune diseases excluding thyroid diseases

688

1215

3.09

134.62

1.2

1.1

24.54

21.65

u/l

0.53

633

1072

Autoimmune diseases excluding thyroid diseases, strict definition

661

1164

3.11

130.86

1.2

1.1

22.71

22.00

u/l

0.12

606

1027

Abnormal serum enzyme levels

304

632

4.72

128.92

1.2

1.1

25.65

28.75

u/l

0.34

288

551

Renal tubulo-interstitial diseases

643

1619

2.93

126.85

1.2

1.1

34.59

18.98

u/l

6.29

595

1422

Transplanted organ and tissue status

144

165

8.99

115.43

1.3

1.1

30.76

27.17

u/l

0.25

138

147

Autoimmune diseases related-to ILD

601

1804

2.80

113.23

1.2

1.1

22.92

23.36

u/l

0.06

555

1591

All kidney diseases

657

1634

2.71

109.82

1.2

1.1

31.85

18.82

u/l

4.94

608

1435

First line medication for Crohn's disease

679

1348

2.72

107.25

1.2

1.1

26.59

20.74

u/l

1.38

637

1165

Primary biliary cholangitis, wide definition

21.82

105.69

1.2

1.0

28.77

31.14

u/l

0.09

Glomerular diseases

204

382

5.45

103.28

1.2

1.1

35.88

26.60

u/l

0.84

194

339

Glomerular disorders in diseases classified elsewhere

158

231

7.03

102.89

1.2

1.1

40.15

26.56

u/l

1.08

150

205

Fibrosis and cirrhosis of liver

134

167

8.32

100.59

1.1

36.10

21.57

u/l

2.69

121

149

Autoimmune diseases

650

1230

2.70

98.86

1.2

1.1

25.74

21.51

u/l

0.76

588

1087

ILD medications

687

1438

2.59

98.68

1.2

1.1

27.11

20.93

u/l

1.53

640

1251

ILD medications: prednisolone, methylprednisolone, prednisone

669

1432

2.61

98.66

1.2

1.1

28.47

21.00

u/l

1.97

625

1246

Other bacterial diseases

630

1610

2.61

97.55

1.2

1.1

34.48

18.74

u/l

6.32

575

1423

Fever of other and unknown origin

411

1131

3.17

97.30

1.2

1.1

39.93

20.38

u/l

4.34

376

1016

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

619

1517

2.59

93.63

1.2

1.1

24.08

22.16

u/l

0.38

549

1356

Primary biliary cholangitis (PBC)

20.27

90.93

1.2

1.0

28.17

33.60

u/l

0.23

Insulin, fast-acting

289

788

3.71

90.37

1.2

1.1

39.09

22.45

u/l

2.58

258

697

Inflammatory bowel disease treatment related agents

693

1577

2.45

90.04

1.2

1.1

26.58

21.75

u/l

1.08

640

1383

Other septicaemia

310

835

3.54

89.05

1.2

1.1

37.24

20.50

u/l

4.08

281

725

Used for control exclusion in common control thyroid runs

584

1099

2.69

88.54

1.2

1.1

24.94

21.68

u/l

0.48

530

972

Other bacterial diseases, including avohilmo

637

1606

2.49

88.53

1.2

1.1

32.69

18.40

u/l

6.18

582

1422

Aplastic and other anaemias

372

1089

3.16

88.47

1.2

1.1

36.03

23.38

u/l

2.45

339

944

Acute renal failure

209

460

4.61

87.53

1.2

1.1

45.20

24.84

u/l

2.40

188

393

Other septicaemia, including avohilmo

313

854

3.47

87.44

1.2

1.1

37.07

20.24

u/l

4.20

284

740

Insulin, fast-acting or short human

289

808

3.61

87.08

1.2

1.1

39.09

23.89

u/l

2.21

258

716

Septicaemia

330

904

3.36

86.84

1.2

1.1

36.38

20.01

u/l

4.34

300

785

Disorders of other endocrine glands

341

1063

3.19

84.01

1.2

1.1

29.03

22.20

u/l

0.81

308

945

Explicit Sepsis

337

959

3.23

83.26

1.2

1.1

35.96

22.22

u/l

3.25

307

839

Explicit Sepsis, including avohilmo

340

973

3.19

82.48

1.2

1.1

35.83

22.17

u/l

3.26

310

850

Disorders of gallbladder, biliary tract and pancreas

634

1648

2.41

82.11

1.2

1.1

27.67

21.34

u/l

1.55

566

1463

Heart failure, not strict

505

1289

2.65

81.23

1.2

1.1

35.23

20.16

u/l

4.67

456

1147

L04AD Calcineurin inhibitors

135

215

6.43

81.06

1.3

1.1

30.86

21.28

u/l

1.12

128

197

IBD patients in KELA-register

198

445

4.51

80.78

1.2

19.05

23.29

u/l

0.30

184

399

Implicit Sepsis

499

1421

2.60

79.42

1.2

1.1

33.35

21.32

u/l

2.97

444

1255

Disorders of parathyroid gland

217

524

4.16

79.23

1.2

1.1

28.44

22.53

u/l

0.43

202

457

Bacterial infection, other or unspecified

388

1133

2.91

78.87

1.2

1.1

42.22

19.49

u/l

5.93

356

991

Oral corticosteroids

630

1563

2.37

78.01

1.2

1.1

28.14

21.83

u/l

1.43

580

1370

L04AA Selective immunosuppressants

211

512

4.18

78.01

1.2

1.1

25.99

22.38

u/l

0.51

199

455

Bacterial Sepsis

350

952

3.06

77.36

1.2

1.1

39.25

22.73

u/l

3.09

317

827

Bacterial infection, other or unspecified, including avohilmo

407

1206

2.78

75.79

1.2

1.1

41.39

19.47

u/l

5.94

370

1058

Noninfective enteritis and colitis

335

1123

3.00

75.02

1.2

1.1

21.67

23.36

u/l

0.15

310

995

Malignant neoplasm of breast, HER2-negative

352

732

3.13

74.94

1.2

1.1

17.26

17.89

u/l

0.10

325

634

Malignant neoplasm of breast

352

732

3.13

74.91

1.2

1.1

17.26

17.89

u/l

0.10

325

634

Implicit bacterial Sepsis

317

867

3.16

74.58

1.2

1.1

41.88

23.09

u/l

3.24

284

751

Implicit bacterial Sepsis, including avohilmo

337

925

3.06

74.27

1.2

1.1

40.40

22.89

u/l

3.16

301

805

Inflammatory bowel disease, strict (require KELA)

198

478

4.20

73.67

1.2

19.05

23.21

u/l

0.29

184

428

Malignant neoplasm of breast, HER2-negative, including Hilmo

353

738

3.10

73.53

1.2

1.1

16.68

18.05

u/l

0.24

326

639

Malignant neoplasm of breast, including Hilmo

353

738

3.10

73.51

1.2

1.1

16.68

18.05

u/l

0.24

326

639

Osteopathies and chondropathies

410

1402

2.69

73.48

1.2

1.1

30.63

22.85

u/l

1.24

368

1245

Type 1 diabetes

194

463

4.23

73.07

1.2

1.1

38.05

21.91

u/l

1.68

172

414

Type 1 diabetes, wide definition, subgroup 1

171

370

4.67

73.05

1.2

1.1

39.52

19.50

u/l

2.04

151

335

Persons encountering health services in other circumstances

294

924

3.17

72.25

1.1

27.07

23.31

u/l

0.32

255

810

Hyperparathyroidism

194

463

4.21

72.11

1.2

1.1

26.45

22.56

u/l

0.27

180

405

Inflammatory bowel disease

245

701

3.53

71.49

1.2

19.87

24.13

u/l

0.38

228

628

Diabetic nephropathy, excluding more controls

171

292

4.87

71.04

1.2

1.1

41.46

25.98

u/l

1.41

158

260

Other and unspecified anaemias

325

1030

2.99

71.03

1.2

1.1

37.62

23.67

u/l

2.41

298

890

Malignant neoplasm of breast, HER-positive

294

672

3.30

70.88

1.2

1.1

18.13

18.42

u/l

0.04

278

579

Other anaemias

327

1039

2.97

70.72

1.2

1.1

37.53

23.61

u/l

2.41

299

898

Malignant neoplasm of breast, ER-positive, including Hilmo

294

672

3.29

70.72

1.2

1.1

18.13

18.42

u/l

0.04

278

579

Nonalcoholic fatty liver disease

128

223

5.88

70.24

1.2

1.1

24.29

18.70

u/l

0.98

113

205

Osteoporosis

246

653

3.51

69.23

1.2

1.1

29.48

22.67

u/l

0.72

219

567

Reimbursement for rheumatic diseases

399

1525

2.62

68.99

1.2

1.1

22.49

23.89

u/l

0.24

365

1347

Malignant neoplasm

507

1206

2.48

68.62

1.2

1.1

27.62

20.71

u/l

1.38

469

1047

Malignant neoplasm

506

1203

2.48

68.55

1.2

1.1

27.58

20.72

u/l

1.36

468

1044

Implicit Sepsis, including avohilmo

511

1529

2.40

68.35

1.2

1.1

32.64

21.22

u/l

2.84

454

1359

Insulin, intermediate and long-acting

365

1305

2.72

67.51

1.2

1.1

38.13

21.88

u/l

3.44

326

1150

Insulin medication

396

1247

2.65

67.48

1.2

1.1

38.27

20.51

u/l

4.48

355

1105

Any reimbursement code in KELA

250

321

3.92

66.95

1.2

1.1

18.38

16.03

u/l

0.34

231

285

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

453

1612

2.46

66.92

1.2

1.1

28.90

23.39

u/l

1.17

417

1413

Type 1 diabetes, wide definition

172

401

4.33

66.89

1.2

1.1

40.01

19.18

u/l

2.19

152

362

Insulin, combination of fast acting with intermediate-acting or long-acting

396

1384

2.61

66.83

1.2

1.1

38.27

21.61

u/l

3.99

355

1218

Presence of other functional implants

404

1045

2.67

66.14

1.2

1.1

24.85

24.92

u/l

0.01

343

927

Second line medication for Crohn's disease

396

1549

2.57

66.09

1.2

1.1

21.93

23.37

u/l

0.17

374

1368

Malignant neoplasm, wide definition

503

1215

2.42

64.99

1.2

1.1

26.14

20.62

u/l

1.03

466

1056

Persons encountering health services for specific procedures and health care

608

1625

2.22

64.79

1.2

1.1

30.01

19.51

u/l

3.15

550

1444

Malignant neoplasm, including Hilmo

501

1212

2.42

64.62

1.2

1.1

26.16

20.63

u/l

1.03

464

1052

Diabetic nephropathy

171

403

4.27

64.59

1.2

1.1

41.46

30.17

u/l

0.86

158

355

Hernia of abdominal wall, postoperative

121

216

5.62

63.83

1.2

1.1

33.62

16.33

u/l

1.28

114

174

Diabetic maculopathy, excluding more controls

113

192

6.00

63.58

1.3

1.1

33.85

22.63

u/l

1.04

100

171

Condition for Implicit Sepsis (Organ dysfunction codes)

510

1538

2.31

62.17

1.2

1.1

32.36

20.95

u/l

2.85

455

1367

Solid cancers

487

1194

2.40

62.07

1.2

1.1

25.78

20.83

u/l

0.85

451

1036

5-aminosalicylic acid

166

404

4.16

61.17

1.2

1.1

20.32

20.66

u/l

0.02

151

352

Polyarthropathies

424

1095

2.50

60.26

1.2

29.98

22.89

u/l

1.05

386

977

Solid cancers, including Hilmo

487

1208

2.36

59.65

1.2

1.1

24.29

20.67

u/l

0.59

450

1050

ILD medications: azathioprine

128

260

4.99

59.19

1.2

1.1

27.35

23.90

u/l

0.14

123

222

L02BG Aromatase inhibitors

264

885

2.98

58.11

1.2

1.1

18.48

21.87

u/l

0.57

252

776

Abnormal results of function studies

105

183

5.86

57.63

1.2

1.1

28.14

21.24

u/l

0.54

165

Medicines for HER+ breast cancer

297

1002

2.79

57.20

1.2

1.1

18.02

22.42

u/l

0.93

281

879

Ulcerative colitis

184

507

3.67

56.96

1.2

21.57

22.64

u/l

0.06

170

453

Crohn disease

115

223

5.24

56.13

1.1

1.2

26.05

20.87

u/l

0.21

108

204

Sub-endpoint used in defining T1D endpoints

202

591

3.39

55.37

1.2

1.1

39.89

22.14

u/l

2.09

178

532

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

147

353

4.22

55.23

1.2

1.1

13.67

23.52

u/l

2.77

136

321

L04AX Other immunosuppressants

368

1521

2.43

54.78

1.2

1.1

22.30

22.37

u/l

0.01

347

1345

Ulcerative colitis (strict definition, require KELA)

139

324

4.35

54.31

1.2

1.1

13.72

23.83

u/l

2.63

128

298

Complications of surgical and medical care, not elsewhere classified

573

1840

2.09

54.27

1.2

1.1

27.58

22.23

u/l

1.28

524

1625

Azathioprine

128

280

4.64

54.20

1.2

1.1

27.35

22.94

u/l

0.19

123

244

Any event in cancer register

492

1286

2.24

53.90

1.2

1.1

25.68

21.16

u/l

0.78

449

1126

Budesonide

128

287

4.52

52.58

1.2

1.1

22.00

20.82

u/l

0.09

118

250

Cholelithiasis, broad definition with cholecystitis

508

1573

2.16

52.48

1.2

1.1

23.89

21.68

u/l

0.48

453

1392

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

134

314

4.32

52.02

1.2

1.1

13.63

24.28

u/l

2.73

123

289

Metabolic disorders

535

1515

2.13

51.92

1.2

1.1

30.27

19.81

u/l

2.79

482

1351

Hypertensive diseases (excluding secondary)

294

609

2.82

51.27

1.2

1.1

20.00

15.35

u/l

0.89

271

552

Oxycodone

278

874

2.74

50.98

1.2

1.1

40.66

20.77

u/l

5.00

254

773

Cholangitis (primary sclerosing, PSC)

117

6.92

50.97

1.2

35.96

25.33

u/l

0.89

105

Diabetic retinopathy, strict definition

161

381

3.81

50.76

1.2

1.1

41.03

32.27

u/l

0.54

140

345

Osteoporosis with pathological fracture (FG)

147

6.13

50.52

1.2

1.1

35.04

27.39

u/l

0.30

125

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

494

1562

2.14

50.33

1.1

32.62

20.38

u/l

3.09

442

1390

Implicit viral Sepsis

158

435

3.67

49.06

1.2

1.1

39.32

22.85

u/l

1.75

148

378

Viral Sepsis

158

435

3.67

49.06

1.2

1.1

39.32

22.85

u/l

1.75

148

378

Persons encountering health services in other circumstances, wide

598

1527

2.02

48.79

1.2

1.1

24.36

22.96

u/l

0.19

547

1338

Oedema, not elsewhere classified

227

763

2.93

48.61

1.2

1.1

29.69

20.63

u/l

1.12

203

681

Other disorders of fluid, electrolyte and acid-base balance

228

742

2.92

48.08

1.2

1.1

33.02

21.61

u/l

2.20

205

646

Diseases of oesophagus, stomach and duodenum

573

1688

2.01

47.93

1.1

26.24

21.84

u/l

0.80

515

1509

Cholelithiasis

477

1552

2.11

46.70

1.2

1.1

20.90

21.70

u/l

0.16

425

1374

Heart failure and antihypertensive medication

169

301

3.68

46.15

1.2

1.1

43.05

20.42

u/l

3.13

152

262

Hypertension, essential

420

1066

2.24

45.40

1.2

1.1

23.00

18.54

u/l

1.04

376

960

General symptoms and signs

528

1286

2.06

45.32

1.2

1.1

29.21

19.59

u/l

1.99

464

1157

Ulcerative colitis, NAS

112

255

4.45

45.18

1.2

15.28

22.39

u/l

1.58

105

232

Implicit viral Sepsis, including avohilmo

206

706

2.94

44.56

1.2

1.1

35.76

22.68

u/l

1.72

189

615

Persons encountering health services for other counselling and medical advice, not elsewhere classified

566

1520

1.98

44.52

1.2

1.1

23.67

22.93

u/l

0.10

529

1332

Nutritional anaemias

319

1298

2.36

43.97

1.2

1.1

35.58

22.44

u/l

1.64

286

1139

Hypertensive diseases

419

1075

2.21

43.93

1.2

1.1

21.37

18.90

u/l

0.48

378

968

Hypertension

419

1075

2.21

43.91

1.2

1.1

21.37

18.90

u/l

0.48

378

968

Heart failure,strict

302

856

2.48

43.22

1.2

1.1

39.29

21.58

u/l

3.38

268

746

Acute tubulo-interstitial nephritis

356

1340

2.25

43.18

1.2

1.1

28.60

19.55

u/l

2.84

322

1171

Insulin, fast-acting (human)

103

232

4.49

42.13

1.3

1.1

43.27

18.54

u/l

1.67

212

Influenza and pneumonia

546

1743

1.94

41.79

1.2

1.1

29.98

20.10

u/l

3.96

497

1548

General examination and investigation of persons without complaint and reported diagnosis

330

710

2.42

41.60

1.2

1.1

24.97

22.40

u/l

0.26

310

615

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

507

1519

1.99

41.20

1.1

30.41

19.52

u/l

2.94

447

1360

Finngen Rheumatological endpoints

473

1316

2.05

41.20

1.2

1.1

27.39

20.97

u/l

1.06

430

1179

Other disorders of skin and subcutaneous tissue

431

1787

2.04

40.90

1.2

1.1

30.49

22.27

u/l

1.78

392

1580

All pneumoniae

530

1795

1.92

40.19

1.2

1.1

31.01

20.35

u/l

4.04

481

1596

Primary hyperparathyroidism

115

293

4.00

40.12

1.2

29.28

23.31

u/l

0.25

107

260

Gout

179

508

3.05

39.96

1.1

38.56

26.48

u/l

0.98

157

439

Disorders of mineral metabolism

175

5.00

39.88

1.3

1.1

52.30

24.77

u/l

1.22

158

Pneumonias (Asthma/COPD co-morbidities)

525

1791

1.92

39.63

1.2

1.1

30.15

20.59

u/l

3.45

477

1592

Complications of medical and surgical care

425

1897

2.02

39.60

1.2

1.1

28.55

22.39

u/l

1.14

394

1670

Gastro-oesophageal reflux disease

390

1577

2.10

39.52

1.1

24.64

22.46

u/l

0.29

352

1403

Iron deficiency anaemia

273

1124

2.40

39.39

1.2

1.1

36.99

22.98

u/l

1.46

246

988

Other heart diseases

247

613

2.63

39.31

1.2

1.1

32.32

15.29

u/l

2.28

228

552

Hypothyroidism, levothyroxine purchases

107

123

4.90

39.03

1.2

37.74

10.67

u/l

1.28

113

Hypothyroidism and >3 levothyroxin purchases

107

123

4.90

39.03

1.2

37.74

10.67

u/l

1.28

113

Caries of dentine

151

449

3.27

39.02

1.3

1.1

33.48

28.05

u/l

0.36

140

403

Infections, IBD-co-morbidities

103

157

4.65

38.98

1.1

41.17

15.73

u/l

2.64

142

Hypothyroidism (congenital or acquired)

107

123

4.89

38.97

1.2

38.11

10.67

u/l

1.29

113

Pneumonia, organism unspecified

482

1693

1.96

38.96

1.2

1.1

31.61

20.42

u/l

3.99

436

1503

Diabetes mellitus

524

1577

1.92

38.72

1.2

30.57

19.09

u/l

3.25

466

1414

Ulcer of lower limb, not elsewhere classified

118

319

3.75

37.79

1.2

1.1

53.50

28.59

u/l

1.66

106

285

Hypothyroidism, drug reimbursement

5.74

37.70

1.2

29.92

11.79

u/l

1.14

Other noninfective gastroenteritis and colitis

165

551

3.02

37.60

1.2

20.88

25.55

u/l

0.40

154

484

Diabetes, varying definitions

518

1580

1.91

37.30

1.2

30.81

19.05

u/l

3.35

462

1416

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

157

5.06

36.67

1.2

25.18

24.04

u/l

0.09

137

Other medical care

291

1073

2.29

36.65

1.2

1.1

36.85

21.51

u/l

2.38

262

944

Nausea and vomiting

175

596

2.88

36.63

1.2

1.1

37.36

22.51

u/l

1.51

159

531

Certain infectious and parasitic diseases

466

1175

1.99

36.63

1.2

1.1

28.86

18.99

u/l

2.34

418

1045

Other diseases of blood and blood-forming organs, wide

160

534

3.03

36.61

1.2

1.1

33.85

25.55

u/l

0.86

145

469

Mucosal proctocolitis

213

4.37

36.40

1.2

14.97

23.15

u/l

1.83

197

Type 2 diabetes, wide definition

437

1389

1.99

36.36

1.1

35.76

19.76

u/l

4.33

390

1243

Disorders of thyroid, IBD co-morbidities

107

173

4.26

36.25

1.2

1.1

19.67

14.13

u/l

0.61

155

Dental caries

159

498

3.03

36.15

1.3

1.2

32.77

27.15

u/l

0.41

147

449

Other retinal disorders

375

1382

2.07

36.14

1.2

1.1

33.24

24.21

u/l

1.51

328

1219

Diabetes, insulin treatment (Kela reimbursement)

528

1687

1.87

36.01

1.1

30.41

20.54

u/l

2.65

467

1509

Ulcerative colitis (strict definition, all Crohn cases excluded)

103

263

3.96

35.77

1.2

1.1

13.60

21.80

u/l

2.35

240

Heart failure, strict

329

1056

2.18

35.27

1.1

38.98

23.46

u/l

3.05

290

924

Diabetic maculopathy

110

278

3.80

35.25

1.3

1.1

33.82

35.12

u/l

0.06

252

Hypothyroidism, strict autoimmune

342

1047

2.15

35.22

1.2

1.1

23.31

22.27

u/l

0.12

296

925

Gout, FINNGEN

179

644

2.78

35.20

1.1

38.56

27.44

u/l

0.88

157

556

Type 2 diabetes

502

1549

1.88

34.80

1.1

27.82

19.31

u/l

2.34

449

1390

Diseases of arteries, arterioles and capillaries (FINNGEN)

151

326

3.22

34.74

1.2

1.1

53.24

15.08

u/l

3.16

136

293

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

505

1817

1.86

34.65

1.2

1.1

29.91

20.88

u/l

3.21

459

1614

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

115

325

3.58

34.54

1.1

46.60

25.80

u/l

1.90

100

288

All-cause Heart Failure

323

1042

2.17

34.29

1.1

39.07

23.47

u/l

2.99

285

910

Erysipelas, including avohilmo

380

1402

2.02

33.95

1.1

29.97

19.69

u/l

2.47

345

1235

Complications of procedures, not elsewhere classified

429

1806

1.92

33.93

1.2

1.1

25.84

22.28

u/l

0.67

390

1593

Other heart diseases, wide

452

1429

1.92

33.64

1.2

31.33

19.07

u/l

2.72

408

1287

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

460

1410

1.91

33.58

1.2

1.1

28.85

21.48

u/l

2.06

416

1250

460

1410

1.91

33.58

1.2

1.1

28.85

21.48

u/l

2.06

416

1250

Other and unspecified iron deficiency

213

875

2.45

32.35

1.2

1.1

36.06

23.19

u/l

1.04

190

771

Diabetes medication

521

1683

1.81

32.30

1.1

1.2

30.13

19.54

u/l

2.96

460

1507

Other disorders of skin and subcutaneous tissue, not elsewhere classified

112

326

3.48

32.18

1.2

1.1

37.26

24.19

u/l

1.28

104

287

Erysipelas

294

1185

2.15

32.07

1.1

33.23

19.19

u/l

3.07

264

1040

Disorders of choroid and retina

444

1661

1.88

31.97

1.2

1.1

31.39

22.95

u/l

1.64

389

1477

Disorders of calcium metabolism

134

5.10

31.78

1.2

1.1

59.06

19.04

u/l

1.49

121

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

344

1693

2.00

31.78

1.1

29.93

22.90

u/l

1.12

322

1485

Constipation

477

1769

1.83

31.63

1.2

1.1

23.48

23.59

u/l

0.01

413

1581

Abnormalities of breathing

428

1279

1.92

31.47

1.1

1.2

23.43

21.30

u/l

0.38

378

1153

Other soft tissue disorders, not elsewhere classified

454

1377

1.88

31.37

1.2

1.1

23.83

23.15

u/l

0.09

413

1222

Diarrhoea and gastroenteritis of presumed infectious origin

363

1659

1.96

31.16

1.2

1.1

27.96

21.23

u/l

1.44

323

1479

Other inflammatory liver diseases

119

5.31

30.79

1.1

26.66

18.88

u/l

0.92

106

Cirrhosis of liver, NAS

112

5.48

30.77

1.1

48.26

19.16

u/l

4.19

Other disorders of kidney and ureter

102

288

3.59

30.74

1.2

1.1

28.00

26.59

u/l

0.10

262

Other ulcerative colitis

5.90

30.58

1.2

18.36

25.33

u/l

0.65

Malaise and fatigue

272

985

2.18

30.36

1.1

30.50

21.02

u/l

2.04

240

880

Cardiovascular diseases (excluding rheumatic etc)

270

686

2.26

30.27

1.2

18.86

14.48

u/l

1.32

251

621

Non-invasive ventilation

137

396

3.00

30.09

1.1

1.2

28.76

15.63

u/l

2.43

125

356

Postmenopausal osteoporosis with pathological fracture

161

4.57

29.95

1.2

1.1

36.94

21.46

u/l

0.65

141

Endocrine, nutritional and metabolic diseases

324

776

2.11

29.92

1.2

1.1

20.24

16.93

u/l

0.61

290

700

Pain in limb

406

1360

1.90

29.85

1.2

1.1

22.13

23.38

u/l

0.18

364

1205

Liquid cancers, including Hilmo

197

710

2.46

29.62

1.1

35.56

21.56

u/l

2.63

180

607

Diabetic retinopathy, excluding more controls

184

384

2.71

29.51

1.2

1.1

40.40

24.71

u/l

1.63

163

342

Tramadol

389

1218

1.93

29.29

1.2

1.1

30.52

18.88

u/l

3.11

344

1090

Noninfectious colitis NAS

268

3.58

28.67

1.2

25.50

24.91

u/l

0.02

240

Disorders of lens

361

1154

1.95

28.27

1.2

1.1

30.98

22.20

u/l

1.26

326

1026

Diseases of the digestive system

254

1185

2.14

28.18

1.2

1.1

33.81

23.73

u/l

0.98

229

1040

Other diseases of intestines

496

1566

1.77

28.15

1.2

1.1

27.95

22.25

u/l

0.98

444

1400

Bleeding

426

1650

1.82

27.72

1.2

1.1

30.94

22.79

u/l

1.44

385

1459

Gastrointestinal diseases

234

500

2.35

27.69

1.1

17.18

17.26

u/l

0.01

212

439

Dyspnoea

458

1873

1.77

27.54

1.1

27.80

22.49

u/l

1.21

408

1668

Intestinal infectious diseases

465

1972

1.76

27.48

1.2

1.1

30.19

21.43

u/l

2.10

418

1755

Sleep apnoea

482

1737

1.75

27.35

1.1

20.36

25.01

u/l

1.30

421

1558

Liquid cancers

163

605

2.57

27.21

1.1

36.40

22.47

u/l

2.44

150

514

Vocal cord dysfunction

179

3.96

26.98

1.1

29.65

17.49

u/l

0.36

159

Dermatitis and eczema

542

1899

1.69

26.83

1.2

1.1

23.25

23.29

u/l

0.00

489

1687

Dermatitis

336

1750

1.88

26.16

1.2

1.1

25.86

23.19

u/l

0.32

302

1552

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

316

1648

1.92

26.14

1.2

1.1

29.34

23.17

u/l

0.86

295

1452

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

108

4.58

26.13

1.2

1.1

32.39

17.64

u/l

1.26

Amputation

206

3.83

25.96

1.2

1.1

69.70

26.46

u/l

1.89

179

Gout, strict definition

115

390

2.98

25.74

1.1

37.57

28.70

u/l

0.53

101

342

Systemic connective tissue disorders

208

942

2.22

25.48

1.1

29.07

22.57

u/l

0.85

192

832

Neoplasms

295

762

2.04

25.14

1.2

1.1

23.23

18.71

u/l

0.72

267

663

Hypo-osmolality and hyponatraemia

117

405

2.89

24.85

1.2

1.1

31.63

24.11

u/l

0.57

104

356

Diseases of the skin and subcutaneous tissue

437

1238

1.78

24.58

1.2

1.1

24.74

22.13

u/l

0.38

395

1092

Other diseases of biliary tract

174

4.02

24.54

1.3

1.2

26.59

26.04

u/l

0.04

157

Autoimmune hepatitis, wide definition

5.90

24.50

1.1

25.27

28.85

u/l

0.20

Peripheral artery operations in Hilmo

262

3.39

24.49

1.2

1.1

66.85

25.81

u/l

2.08

232

Diabetic retinopathy

221

621

2.23

24.45

1.2

1.1

36.67

29.78

u/l

0.59

192

551

Benzodiazepine use

486

1949

1.69

24.44

1.2

1.1

21.53

23.64

u/l

0.29

433

1736

Intestinal infectious diseases, including avohilmo, including avohilmo

548

1853

1.65

24.38

1.2

1.1

26.09

21.88

u/l

0.85

488

1651

Gout, unspecified

123

446

2.78

24.37

1.1

40.75

29.21

u/l

0.61

108

388

Other and unspecified dermatitis

285

1476

1.94

24.32

1.2

1.1

23.05

23.34

u/l

0.03

262

1309

Medical observation and evaluation for suspected diseases and conditions

282

710

2.04

23.89

1.2

1.1

28.97

22.40

u/l

0.84

252

615

Hypothyroidism, other/unspecified

424

1605

1.74

23.78

1.2

1.1

25.00

22.89

u/l

0.22

373

1435

Other cataract

241

864

2.08

23.72

1.2

1.1

33.42

23.41

u/l

1.28

219

758

Sleep apnoea, including avohilmo

485

1753

1.68

23.35

1.1

19.66

24.95

u/l

1.63

426

1570

Cardiac arrhythmias

271

870

2.00

23.29

1.2

26.64

15.47

u/l

2.43

237

781

Gout, idiopatic and unspecified

144

579

2.51

23.21

1.1

39.72

27.73

u/l

0.79

125

501

Obesity due to excess calories

249

1252

2.00

23.19

1.1

1.2

21.24

22.85

u/l

0.21

223

1132

Ulcerative rectosigmoiditis

134

4.38

23.16

1.2

1.1

10.85

22.79

u/l

3.11

125

Disorders of the thyroid gland

444

1692

1.71

23.13

1.2

1.1

25.41

23.14

u/l

0.26

399

1514

Abnormal findings on diagnostic imaging of lung

256

1233

1.98

22.88

1.2

1.1

30.77

23.62

u/l

1.24

240

1073

Symptoms and signs involving the digestive system and abdomen

440

1276

1.73

22.81

1.2

1.1

25.02

22.74

u/l

0.34

389

1133

Atrial fibrillation and flutter

163

431

2.45

22.75

1.2

1.1

33.92

15.88

u/l

2.49

144

391

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

138

531

2.54

22.70

1.2

1.1

51.89

22.67

u/l

2.24

124

450

Seropositive rheumatoid arthritis

141

565

2.50

22.60

1.1

23.92

23.15

u/l

0.09

130

502

Opioids

426

1268

1.74

22.57

1.2

1.1

25.59

18.43

u/l

1.85

383

1137

Sulfasalazine

153

641

2.40

22.55

1.2

1.1

21.39

21.82

u/l

0.03

137

564

Other functional intestinal disorders

245

1118

2.00

22.50

1.2

1.1

24.73

23.77

u/l

0.07

220

992

Agranulocytosis

257

3.31

22.47

1.3

1.2

27.61

22.06

u/l

0.42

227

Hyperkalaemia

113

4.67

22.43

1.2

1.1

40.47

25.52

u/l

0.53

103

Vitreous haemorrhage

225

3.46

22.15

1.3

1.1

37.13

27.23

u/l

0.60

201

Symptoms and signs involving the urinary system

378

1636

1.75

22.10

1.1

28.63

23.36

u/l

0.85

333

1452

Abnormal findings on diagnostic imaging of other body structures

341

2.93

21.65

1.1

33.38

21.10

u/l

0.88

302

Chronic pancreatitis

245

3.30

21.37

1.2

1.1

35.86

28.28

u/l

0.35

220

Heart failure and coronary heart disease

224

765

2.06

21.22

1.2

1.1

42.55

24.41

u/l

2.53

196

657

Infections of the skin and subcutaneous tissue

282

1498

1.86

21.18

1.2

1.1

31.26

22.53

u/l

1.03

256

1336

Other arthritis (FG)

160

703

2.29

21.18

1.2

1.1

31.45

22.03

u/l

0.64

145

632

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

131

241

2.73

20.99

1.2

1.1

22.96

13.37

u/l

1.98

119

216

Complications of internal orthopaedic prosthetic devices, implants and grafts

141

589

2.41

20.99

1.3

1.1

30.15

25.93

u/l

0.33

128

507

Other special examinations and investigations of persons without complaint or reported diagnosis

274

710

1.96

20.98

1.1

26.87

22.40

u/l

0.48

243

615

Cerebrovascular diseases (FINNGEN)

156

461

2.38

20.97

1.2

1.1

40.38

15.38

u/l

2.13

139

419

Diseases of peritoneum

234

3.33

20.86

1.2

20.41

23.98

u/l

0.41

210

Other systemic involvement of connective tissue (FG)

139

567

2.42

20.82

1.1

29.58

23.26

u/l

0.50

123

503

Hypothyreosis and Thyroxine purchase for inclusion criteria

435

1716

1.66

20.78

1.2

1.1

24.77

22.75

u/l

0.22

383

1538

Cholecystectomy

362

1792

1.72

20.51

1.2

1.1

21.04

24.71

u/l

0.80

328

1585

Exposure to unspecified factor

473

1994

1.62

20.34

1.2

1.1

29.37

21.79

u/l

1.64

407

1794

Other diseases of the digestive system

170

780

2.19

20.28

1.2

1.1

35.39

26.98

u/l

0.52

153

678

Rheumatoid arthritis

179

743

2.14

19.78

1.1

22.83

24.09

u/l

0.18

162

660

Cardiovascular diseases

223

577

2.06

19.72

1.2

18.68

14.57

u/l

0.95

204

523

Other nutritional deficiencies

327

1719

1.74

19.64

1.1

1.2

20.81

23.47

u/l

0.51

293

1536

Senile cataract

311

1050

1.81

19.53

1.2

1.1

29.01

22.31

u/l

0.78

280

927

Other disorders of urethra and urinary system

351

1418

1.73

19.48

1.2

1.1

22.31

23.60

u/l

0.20

313

1271

Hard cardiovascular diseases

402

1422

1.67

19.30

1.1

31.91

19.98

u/l

2.30

364

1275

Pain in throat and chest

366

1265

1.72

19.24

1.1

1.2

23.67

21.45

u/l

0.30

327

1140

Other and unspecified disorders of skin and subcutaneous tissue

129

4.09

19.00

1.2

28.76

22.72

u/l

0.42

115

Codeine

391

1258

1.68

18.78

1.1

21.50

18.50

u/l

0.59

346

1127

Parasetamol

274

738

1.88

18.70

1.2

26.50

20.46

u/l

0.89

246

668

Depression medications

129

3.32

18.68

1.1

1.2

18.01

10.54

u/l

1.50

117

Hyperlipidaemia, other/unspecified

198

887

2.02

18.67

1.2

1.1

29.58

20.94

u/l

1.15

172

779

Atrial fibrillation and flutter with reimbursement

132

340

2.46

18.52

1.2

1.1

28.86

15.64

u/l

3.06

116

304

Enlarged lymph nodes

310

2.86

18.51

1.1

33.80

19.56

u/l

1.39

282

Abdominal and pelvic pain

418

1276

1.65

18.26

1.2

1.1

23.60

22.74

u/l

0.10

363

1133

Other diseases of pancreas

184

3.47

18.22

1.1

1.2

48.84

24.33

u/l

1.13

164

All influenza

131

566

2.33

18.10

1.2

1.1

27.77

22.98

u/l

0.53

119

494

Exclusions for E4_PCOS_BROAD

364

2.68

18.08

1.2

1.1

37.35

23.37

u/l

0.53

329

Missing teeth due to accident, extraction or parodontitis

317

1654

1.72

18.06

1.2

1.1

24.22

24.43

u/l

0.02

272

1478

Implicit fungal Sepsis, including avohilmo

143

3.82

18.04

1.1

30.64

23.52

u/l

0.30

128

Valvular heart disease excluding rheumatic fever

224

830

1.93

18.01

1.1

33.61

20.00

u/l

1.57

203

738

Non-rheumatic valve diseases

223

827

1.93

17.85

1.1

33.26

20.07

u/l

1.49

202

735

Other diseases of pleura

226

1039

1.90

17.83

1.1

35.35

24.55

u/l

1.81

200

899

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

190

583

2.06

17.72

1.2

1.1

23.54

15.66

u/l

1.93

178

530

Certain infectious and parasitic diseases, including avohilmo

304

855

1.79

17.63

1.2

1.1

25.43

21.57

u/l

0.50

277

758

Percutaneous Coronary Intervention

382

1410

1.65

17.58

1.1

32.98

21.71

u/l

1.83

348

1256

COPD/asthma/ILD related infections

450

1410

1.60

17.57

1.2

1.1

23.70

21.48

u/l

0.45

412

1250

COPD/asthma related infections

450

1410

1.60

17.57

1.2

1.1

23.70

21.48

u/l

0.45

412

1250

Antihypertensive medication - note that there are other indications

218

575

1.99

17.57

1.2

18.61

17.13

u/l

0.24

200

510

Asthma, unspecified (mode), excluding more controls

228

859

1.90

17.56

1.1

17.31

18.44

u/l

0.23

209

759

Ischemic heart diseases

398

1453

1.63

17.51

1.1

29.93

21.38

u/l

1.47

362

1295

Obesity and other hyperalimentation

305

1676

1.72

17.49

1.1

1.2

21.53

22.97

u/l

0.22

274

1499

Iron deficiency anaemia secondary to blood loss (chronic)

360

2.66

17.43

1.2

1.1

34.80

26.16

u/l

0.46

319

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

459

1879

1.57

17.37

1.2

1.1

24.85

21.72

u/l

0.63

409

1672

Obesity

303

1668

1.72

17.37

1.1

1.2

21.53

23.05

u/l

0.23

273

1491

GI-bleeding

161

773

2.09

17.18

1.2

1.1

36.86

27.14

u/l

0.59

144

673

Other disorders of adrenal gland

4.72

17.07

1.1

1.2

23.88

21.07

u/l

0.18

Hydronephrosis

212

3.19

17.05

1.1

37.67

23.20

u/l

0.84

187

Other specified/unspecified arthritis

144

666

2.17

16.95

1.1

31.77

23.06

u/l

0.51

130

596

Asthma, excluding more controls

303

885

1.76

16.93

1.1

18.95

18.05

u/l

0.16

281

784

Syncope and collapse

204

885

1.93

16.88

1.1

27.92

20.44

u/l

0.91

180

790

Disorders of lipoprotein metabolism and other lipidaemias

377

1404

1.64

16.76

1.2

1.1

29.02

20.44

u/l

2.05

333

1255

Volume depletion

186

3.31

16.50

1.3

1.1

37.13

27.59

u/l

0.52

167

Emergency coronary revascularization (for ACS)

403

1522

1.60

16.46

1.1

32.52

22.43

u/l

1.63

366

1350

Family history of malignant neoplasm

238

3.01

16.40

1.1

16.44

16.93

u/l

0.05

219

Excluding asthma or asthma-COPD overlap

331

977

1.70

16.32

1.2

1.1

21.86

20.49

u/l

0.22

304

859

Cellulitis

117

506

2.33

16.22

1.2

1.1

35.98

22.07

u/l

1.15

107

449

Other and unspecified polyneuropathies, also in other diseases

108

451

2.41

16.21

1.2

1.1

43.84

26.86

u/l

0.92

100

397

Diseases of arteries, arterioles and capillaries

315

1378

1.68

16.13

1.2

1.1

42.73

21.39

u/l

3.23

286

1213

Major coronary heart disease event

397

1488

1.60

16.09

1.1

32.96

21.77

u/l

1.91

361

1320

Drug-induced neutropenia

170

3.40

16.02

1.2

31.00

20.41

u/l

0.67

153

Symptoms and signs involving the circulatory and respiratory systems

408

1279

1.60

15.99

1.1

1.2

22.80

21.30

u/l

0.23

367

1153

Coronary revascularization (ANGIO or CABG)

375

1411

1.62

15.98

1.1

33.30

21.69

u/l

1.86

341

1257

Injuries to the hip and thigh

238

1192

1.80

15.94

1.2

1.1

32.92

24.19

u/l

0.95

204

1053

Symptoms and signs concerning food and fluid intake

195

3.20

15.90

1.0

1.1

17.32

22.60

u/l

0.69

178

Other pulmonary diagnosis

329

977

1.69

15.89

1.2

1.1

21.58

20.49

u/l

0.17

302

859

Other bacterial intestinal infections

395

2.50

15.89

1.1

37.15

23.97

u/l

1.03

352

Fracture of femur

146

626

2.11

15.72

1.2

1.1

37.74

25.85

u/l

0.86

122

544

Diseases of the ear and mastoid process

489

1606

1.53

15.70

1.2

1.1

24.49

21.88

u/l

0.52

451

1420

Pain in joint

253

869

1.79

15.69

1.2

1.1

16.14

24.49

u/l

2.91

228

779

Presence of cardiac and vascular implants and grafts

188

713

1.95

15.57

1.2

1.1

34.54

26.97

u/l

0.78

169

618

Other diseases of anus and rectum

159

786

2.02

15.57

1.1

22.33

24.37

u/l

0.26

130

696

STROKE

264

1015

1.76

15.57

1.1

36.05

19.13

u/l

2.33

238

910

Thyrotoxicosis, other and/or unspecified

116

510

2.29

15.51

1.2

1.1

15.51

22.19

u/l

1.71

107

458

ILD, hospital admission 2, with pulmonary infections

199

3.15

15.46

1.2

1.1

32.89

28.16

u/l

0.22

177

Fracture of lumbar spine and pelvis

124

561

2.22

15.37

1.1

27.91

26.95

u/l

0.09

113

493

Asthma

316

967

1.69

15.33

1.1

19.21

20.61

u/l

0.24

293

849

Other symptoms and signs involving the digestive system and abdomen

396

2.47

15.32

1.1

1.2

23.25

20.68

u/l

0.20

356

Chronic apical periodontitis

486

1803

1.51

15.32

1.2

1.1

21.76

23.37

u/l

0.29

433

1610

Sequelae with surgical and medical care as external cause

116

513

2.28

15.31

1.2

1.1

29.15

26.10

u/l

0.27

108

452

Fall on same level

490

1728

1.51

15.29

1.2

1.1

27.72

21.24

u/l

1.35

427

1556

Polyneuropathies and other disorders of the peripheral nervous system

117

520

2.26

15.25

1.2

1.1

42.97

25.24

u/l

1.09

108

459

Type 2 diabetes, definitions combined, including avohilmo

410

1516

1.57

15.16

1.1

26.47

20.40

u/l

1.29

371

1359

Non-ischemic cardiomyopathy

161

634

2.02

15.11

1.1

33.10

21.81

u/l

2.09

139

550

Asthma, unspecified (mode)

233

939

1.80

15.04

1.1

17.58

21.06

u/l

0.86

214

822

COPD differential diagnosis

325

978

1.67

14.99

1.2

1.1

21.93

20.77

u/l

0.17

298

859

ILD differential diagnosis

325

978

1.67

14.98

1.2

1.1

21.93

20.77

u/l

0.17

298

859

Other bacterial intestinal infections, including avohilmo

121

550

2.21

14.94

1.1

33.10

22.04

u/l

1.02

108

483

Heart failure and bmi 25plus

180

615

1.96

14.92

1.1

38.04

21.30

u/l

2.23

161

541

Other disorders of glucose regulation and pancreatic internal secretion

158

3.39

14.90

1.3

1.1

26.50

23.77

u/l

0.17

141

Intestinal stricture

162

823

1.98

14.89

1.2

1.1

34.42

25.53

u/l

0.74

153

718

Unspecified urinary incontinence

225

2.97

14.87

1.1

23.70

24.05

u/l

0.02

205

509

1728

1.50

14.84

1.2

1.1

22.36

23.00

u/l

0.11

459

1534

Hypothyroidism, strict autoimmune, 3 medication purchases required

378

1615

1.58

14.79

1.2

1.1

22.81

22.75

u/l

0.01

326

1448

Pain, not elsewhere classified

133

635

2.10

14.50

1.1

18.16

19.24

u/l

0.16

119

573

Other diseases of stomach and duodenum

118

3.77

14.50

1.2

27.33

28.52

u/l

0.06

106

Bacterial intestinal infections, IBD co-morbidities

100

425

2.37

14.49

1.1

40.63

24.94

u/l

1.16

376

Cough

196

996

1.84

14.42

1.2

1.1

20.34

23.51

u/l

0.40

174

891

Recurrent or chronic depression

186

679

1.91

14.39

1.2

22.49

21.48

u/l

0.08

164

623

Dipeptidyl peptidase 4 (DPP-4) inhibitors

267

1239

1.70

14.34

1.1

1.2

32.30

23.77

u/l

1.21

233

1097

Follow-up examination after treatment for conditions other than malignant neoplasms

185

646

1.91

14.33

1.2

1.1

17.71

21.88

u/l

0.98

169

561

Low back pain

346

1470

1.59

14.17

1.2

1.1

17.73

24.02

u/l

2.39

304

1309

Hypertensive heart and/or renal disease

125

419

2.19

14.15

1.2

1.1

33.75

20.24

u/l

1.63

111

364

Other (not insulin) diabetes medications

426

1641

1.53

14.13

1.1

26.14

19.99

u/l

1.46

376

1469

Sleep disorders (combined)

474

1654

1.50

14.12

1.1

20.44

24.29

u/l

0.92

420

1479

Rheumatoid arthritis, including avohilmo

194

1065

1.83

14.11

1.1

24.28

23.21

u/l

0.15

175

948

Type 2 diabetes, strict (exclude DM1)

407

1541

1.54

14.02

1.1

27.11

20.38

u/l

1.48

366

1381

Sequelae of external causes of morbidity and mortality

136

664

2.06

14.01

1.2

1.1

33.01

25.34

u/l

0.72

127

582

Type 2 diabetes, definitions combined

403

1524

1.54

13.96

1.1

27.23

19.46

u/l

1.86

362

1366

Cutaneous abscess, furuncle and carbuncle

123

579

2.13

13.94

1.2

1.1

27.21

23.46

u/l

0.22

113

519

Asthma (only as main-diagnosis), excluding more controls

272

885

1.70

13.88

1.1

20.73

18.05

u/l

0.42

251

784

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

4.33

13.85

1.2

1.1

26.03

27.15

u/l

0.05

Other diseases of urinary system

427

1578

1.52

13.85

1.2

1.1

23.72

23.89

u/l

0.02

376

1415

Asthma (mode)

307

978

1.65

13.85

1.1

19.29

20.77

u/l

0.26

282

859

Peripheral artery disease

209

921

1.80

13.84

1.2

1.1

45.65

24.29

u/l

2.51

188

796

Special screening examination for other diseases and disorders

218

2.91

13.79

1.2

1.1

17.28

24.91

u/l

0.86

187

Thyrotoxicosis with diffuse goitre

332

2.52

13.75

1.2

1.1

13.43

20.43

u/l

1.87

298

Intracranial trauma

239

930

1.74

13.75

1.2

1.1

24.37

20.55

u/l

0.42

201

840

Other systemic involvement of connective tissue

142

710

2.01

13.71

1.1

29.81

23.00

u/l

0.59

126

627

Thyrotoxicosis

138

684

2.03

13.66

1.2

1.1

15.91

23.12

u/l

2.06

126

609

Hypokalaemia

264

2.71

13.63

1.1

37.28

22.42

u/l

1.81

237

Familial hypercholesterolemia, with ischemic heart disease

188

3.06

13.62

1.2

1.1

56.33

29.14

u/l

0.96

165

Nerve, nerve root and plexus disorders

468

1899

1.48

13.60

1.2

1.1

24.14

23.17

u/l

0.14

430

1681

Psoriatic and enteropathic arthropathies

226

2.85

13.54

1.1

23.81

23.36

u/l

0.01

200

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

172

926

1.87

13.35

1.2

1.1

25.33

22.53

u/l

0.15

156

827

Chronic laryngitis and laryngotracheitis

331

2.50

13.34

1.2

28.58

23.79

u/l

0.13

299

Other respiratory diseases principally affecting the interstitium

436

2.29

13.26

1.2

1.1

30.41

26.87

u/l

0.27

384

Elevated blood glucose level

150

3.30

13.25

1.2

1.1

45.51

23.63

u/l

1.14

132

Other symptoms and signs involving the nervous and musculoskeletal systems

201

1137

1.77

13.25

1.2

1.1

24.93

23.03

u/l

0.12

181

1014

Other abnormal findings of blood chemistry

4.25

13.18

1.4

1.2

17.21

25.95

u/l

0.64

Other/unspecified seropositive rheumatoid arthritis

141

716

1.98

13.06

1.1

23.92

23.79

u/l

0.01

130

636

Continuous positive airway pressure

274

2.50

12.99

1.1

1.2

17.50

16.69

u/l

0.11

243

Gastroduodenal ulcer

123

595

2.07

12.90

1.1

37.26

29.20

u/l

0.58

106

518

AV-block

314

2.41

12.87

1.1

28.96

25.90

u/l

0.24

272

Persons encountering health services for examination and investigation

244

710

1.73

12.85

1.1

24.15

22.40

u/l

0.18

222

615

Supplementary factors related to causes of morbidity and mortality classified elsewhere

149

776

1.93

12.82

1.2

1.1

34.83

23.76

u/l

0.84

127

691

Vitamin B12 deficiency anaemia

211

2.87

12.82

1.2

1.1

20.00

28.04

u/l

1.10

187

Seropositive rheumatoid arthritis, wide

141

721

1.97

12.82

1.1

23.92

23.86

u/l

0.01

130

641

Leisure time condition

400

2.31

12.71

1.1

30.29

23.60

u/l

0.43

360

Fitting and adjustment of other devices

173

830

1.84

12.67

1.2

1.1

27.13

23.25

u/l

0.33

159

722

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

138

705

1.97

12.59

1.2

1.1

24.10

23.62

u/l

0.05

127

625

Papulosquamous disorders

191

1082

1.77

12.57

1.2

1.1

21.70

24.27

u/l

0.21

171

968

Other disorders of ear

408

1767

1.49

12.57

1.2

1.1

25.28

23.67

u/l

0.22

375

1559

Diseases of external ear

168

917

1.84

12.51

1.1

26.36

24.88

u/l

0.11

155

811

Other arrhythmias

277

1281

1.62

12.43

1.1

20.92

19.22

u/l

0.36

247

1152

Mycoses

137

701

1.96

12.43

1.1

31.36

24.67

u/l

0.58

120

624

Other CVD (FINNGEN)

162

2.89

12.42

1.1

34.25

17.06

u/l

0.70

142

Covid-19 confirmed case

176

976

1.81

12.39

1.2

1.1

32.29

24.08

u/l

1.15

161

850

Codeine or tramadol medication

475

1776

1.45

12.37

1.2

1.1

21.70

23.59

u/l

0.35

411

1592

Psoriasis

142

737

1.94

12.37

1.2

1.1

23.06

23.70

u/l

0.03

127

661

Other specific joint derangements/joint disorders

292

1134

1.61

12.35

1.2

19.01

22.08

u/l

0.63

265

1018

Coagulation defects, purpura and other haemorrhagic conditions

100

456

2.21

12.35

1.3

1.1

32.18

24.20

u/l

0.48

409

Paralytic ileus and intestinal obstruction

129

649

2.00

12.26

1.3

1.1

36.89

25.56

u/l

0.76

120

569

Primary_lymphoid and hematopoietic malignant neoplasms

121

596

2.04

12.24

1.1

37.78

27.09

u/l

1.09

110

519

Asthma (only as main-diagnosis)

281

967

1.63

12.21

1.1

20.84

20.61

u/l

0.03

259

849

Myocardial infarction

217

883

1.72

12.19

1.1

45.08

22.19

u/l

2.11

193

767

Faecal incontinence

207

2.83

12.09

1.1

14.02

22.10

u/l

1.93

184

Familial hypercholesterolemia

318

2.44

11.97

1.2

1.1

51.45

24.37

u/l

1.22

280

Viral infections characterized by skin and mucous membrane lesions

191

1097

1.75

11.97

1.2

1.1

23.85

24.54

u/l

0.07

173

973

Episodal and paroxysmal disorders

442

1531

1.47

11.85

1.1

22.42

23.48

u/l

0.19

395

1367

Zoster [herpes zoster], including avohilmo

251

1499

1.62

11.83

1.2

1.1

20.73

25.05

u/l

0.93

225

1326

Unspecified haematuria

188

872

1.76

11.76

1.1

25.54

24.51

u/l

0.10

167

769

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

390

2059

1.48

11.74

1.2

1.1

20.73

23.68

u/l

0.77

352

1833

Presence of other devices

116

562

2.04

11.73

1.2

1.1

20.17

26.12

u/l

0.83

108

484

Diseases of the respiratory system

269

825

1.64

11.70

1.1

21.67

23.26

u/l

0.21

244

728

Zoster [herpes zoster]

102

481

2.13

11.61

1.2

1.1

22.86

26.72

u/l

0.32

426

Peripheral arterial reconstruction

372

2.30

11.61

1.2

1.1

52.93

28.40

u/l

1.43

323

Gonarthrosis [arthrosis of knee](FG)

311

1148

1.56

11.51

1.2

1.1

24.35

22.70

u/l

0.15

273

1026

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

413

2.22

11.41

1.2

1.1

54.05

23.84

u/l

1.87

353

Pure hypercholesterolaemia

324

1342

1.54

11.36

1.2

1.1

28.44

20.87

u/l

1.45

289

1198

Seronegative rheumatoid arthritis

243

2.61

11.33

1.1

19.02

23.18

u/l

0.50

214

Candidiasis, including avohilmo

146

790

1.86

11.24

1.2

1.1

25.75

22.90

u/l

0.25

127

705

Malignant neoplasm of breast, HER-negative

104

480

2.09

11.20

1.1

16.61

17.85

u/l

0.16

409

Other interstitial pulmonary diseases

366

2.28

11.17

1.2

1.1

31.15

28.34

u/l

0.17

321

Haemorrhage from respiratory passages

152

734

1.84

11.16

1.2

1.1

27.29

25.27

u/l

0.23

133

651

Genitourinary diseases

189

533

1.78

11.14

1.2

26.44

21.90

u/l

0.42

167

473

ILD, hospital admissions 1, main diag only

305

2.41

11.11

1.2

1.1

30.52

29.40

u/l

0.06

268

Interstitial lung disease endpoints

367

2.28

11.10

1.2

1.1

31.15

28.40

u/l

0.16

322

Interstitial lung disease

367

2.28

11.10

1.2

1.1

31.15

28.40

u/l

0.16

322

Diseases of the eye and adnexa

292

928

1.58

11.02

1.2

1.1

20.12

20.50

u/l

0.04

262

836

Other reaction to severe stress, and adjustment disorders

159

889

1.79

10.97

1.2

1.1

36.22

19.35

u/l

1.21

149

803

Injuries to the abdomen, lower back, lumbar spine and pelvis

180

1029

1.73

10.95

1.1

25.78

24.09

u/l

0.20

161

906

ILD, hospital admissions

357

2.28

10.93

1.2

1.1

31.30

28.39

u/l

0.17

312

Disorders of vitreous body and globe

256

1537

1.58

10.86

1.2

1.1

24.57

25.09

u/l

0.05

235

1360

Disorders of synovium and tendon

235

1236

1.62

10.82

1.1

29.69

23.54

u/l

0.60

211

1095

Gastric ulcer

403

2.20

10.81

1.1

1.2

41.93

28.59

u/l

0.85

347

Corns and callosities

128

3.24

10.81

1.4

1.1

42.56

20.18

u/l

0.72

117

Statin medication

276

984

1.58

10.78

1.2

1.1

17.61

22.75

u/l

1.51

250

894

Soft tissue disorders

396

1383

1.47

10.78

1.2

1.1

23.50

23.12

u/l

0.04

352

1227

Irritable bowel syndrome

130

688

1.90

10.75

1.1

16.89

22.03

u/l

1.07

116

621

Mood disorders, excluding more controls

396

1597

1.46

10.74

1.2

1.1

22.72

21.22

u/l

0.16

346

1430

Coxarthrosis [arthrosis of hip](FG)

232

980

1.63

10.73

1.1

24.23

22.46

u/l

0.22

197

871

Sensorineural hearing loss

337

1501

1.50

10.70

1.2

1.1

25.14

24.47

u/l

0.07

298

1322

Disorders of vitreous body

250

1509

1.58

10.66

1.2

1.1

24.74

25.09

u/l

0.03

230

1341

Lower back pain or/and sciatica

453

1988

1.42

10.66

1.1

18.41

24.48

u/l

2.40

401

1775

Other antidepressants

419

1479

1.45

10.62

1.2

21.68

25.30

u/l

0.75

377

1322

Atherosclerosis, excluding cerebral and coronary sclerosis

188

867

1.71

10.57

1.2

1.1

47.28

24.51

u/l

2.38

168

744

Malignant neoplasm of breast, ER-negative, including Hilmo

108

503

2.02

10.55

1.1

16.48

17.85

u/l

0.19

430

Carbimazole or st.post thyroidectomy, condition for graves disease

109

547

2.00

10.55

1.1

1.2

14.83

21.09

u/l

1.87

103

493

Problems related to lifestyle

156

2.97

10.54

1.2

1.1

65.12

27.44

u/l

0.64

142

Cholecystitis

294

2.39

10.54

1.1

40.11

25.54

u/l

0.87

262

Functional dyspepsia

129

686

1.89

10.52

1.2

1.1

22.29

23.25

u/l

0.09

109

615

Type of accident

134

723

1.86

10.45

1.2

1.1

36.18

22.47

u/l

1.01

113

643

Pain (limb, back, neck, head abdominally)

277

883

1.57

10.37

1.1

25.86

24.72

u/l

0.09

243

789

Malignant neoplasm of prostate

104

293

2.11

10.36

1.2

1.1

18.27

26.29

u/l

1.16

251

Headache

248

1212

1.58

10.36

1.1

20.66

19.53

u/l

0.11

216

1092

Other joint disorders

333

1154

1.51

10.34

1.2

17.63

21.97

u/l

1.32

293

1035

Chronic lower respiratory diseases

494

1870

1.39

10.18

1.2

1.1

20.42

23.69

u/l

0.82

448

1665

malignant neoplasm of male genital organs, including Hilmo

106

308

2.07

10.18

1.2

1.1

17.97

25.94

u/l

1.22

266

malignant neoplasm of male genital organs

105

305

2.08

10.17

1.2

1.1

18.06

26.12

u/l

1.23

263

Viral pneumonia

251

2.48

10.13

1.2

1.1

35.34

24.46

u/l

0.56

225

Alcoholic liver disease

194

2.70

10.03

1.1

46.84

31.18

u/l

0.48

173

Major coronary heart disease event excluding revascularizations

258

1089

1.57

10.02

1.1

40.11

21.44

u/l

2.09

233

954

Acute pancreatitis

416

2.13

10.02

1.2

1.1

47.06

24.45

u/l

0.82

368

Weight loss

223

2.58

10.01

1.0

1.1

17.40

26.53

u/l

1.31

197

Myocardial infarction, without ST-elevation

178

950

1.70

10.00

1.1

48.24

25.69

u/l

1.92

157

824

Myocardial infarction, strict

196

834

1.67

9.93

1.1

46.03

22.87

u/l

2.06

173

722

Fentanyl

212

2.61

9.91

1.1

55.68

28.66

u/l

1.41

183

Depression

396

1855

1.43

9.90

1.2

1.1

22.60

23.24

u/l

0.06

346

1668

Coronary atherosclerosis

278

1142

1.54

9.89

1.2

1.1

36.87

22.26

u/l

2.21

251

1008

Acute bronchitis

179

1047

1.68

9.88

1.2

1.1

27.40

23.56

u/l

0.55

159

924

Conductive and sensorineural hearing loss

347

1575

1.47

9.87

1.2

1.1

24.24

23.90

u/l

0.04

308

1394

Arthropathies

339

1154

1.49

9.83

1.2

21.79

21.97

u/l

0.02

311

1035

Sicca syndrome [Sjögren]

202

2.65

9.83

1.1

1.2

25.30

20.72

u/l

0.41

178

Neurological diseases, wide definition

197

2.25

9.81

1.2

1.1

23.95

16.77

u/l

0.75

178

Anxiety disorders, excluding more controls

343

1496

1.47

9.77

1.2

1.1

27.85

21.03

u/l

0.79

310

1348

Chronic periodontitis, including avohilmo

426

1932

1.41

9.75

1.2

1.1

18.07

25.07

u/l

3.62

378

1721

Viral and other specified intestinal infections

334

2.23

9.72

1.3

1.2

30.90

16.51

u/l

0.75

300

Malignant neoplasm of prostate, including Hilmo

103

296

2.06

9.71

1.2

1.1

18.42

26.24

u/l

1.12

254

Any mental disorder

451

1611

1.40

9.67

1.2

1.1

27.91

21.23

u/l

1.03

400

1442

Secondary uncertain malignant neoplasm

269

2.39

9.66

1.2

1.1

57.01

21.99

u/l

2.95

227

Idiopathic gout

181

2.73

9.65

1.0

1.1

30.84

34.46

u/l

0.20

161

Diseases of pulp and periapical tissues, including avohilmo

415

1512

1.42

9.60

1.2

1.1

21.61

24.49

u/l

0.51

373

1347

Acute upper respiratory infections

442

1898

1.40

9.56

1.2

1.1

21.42

23.81

u/l

0.55

404

1682

Periodontitis

425

1933

1.40

9.52

1.2

1.1

18.03

25.05

u/l

3.64

379

1722

Other metabolic disorders

309

2.28

9.47

1.1

1.2

30.69

17.15

u/l

0.37

279

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

328

2.24

9.46

1.1

31.43

23.51

u/l

0.88

281

Urinary track infection

261

841

1.56

9.38

1.2

1.1

21.23

19.99

u/l

0.18

228

765

Neurological diseases

324

1097

1.49

9.37

1.2

1.1

24.99

22.42

u/l

0.33

288

984

Falls/tendency to fall

421

1496

1.41

9.33

1.2

1.1

27.26

21.69

u/l

0.98

368

1357

Other acute lower respiratory infections

220

1334

1.57

9.31

1.2

1.1

29.11

24.52

u/l

0.68

197

1181

Other or unspecified ileus, impaction or obstruction

422

2.07

9.28

1.3

1.1

27.00

26.48

u/l

0.03

370

Ischaemic heart disease, wide definition

340

1441

1.45

9.24

1.2

1.1

35.22

21.89

u/l

1.98

304

1281

Pyogenic arthritis

125

3.07

9.23

1.2

1.1

30.42

27.07

u/l

0.09

112

Dental operations

232

751

1.59

9.20

1.1

26.18

25.96

u/l

0.02

210

675

Immunodeficiencies

3.41

9.19

1.4

1.2

45.63

24.78

u/l

0.74

Smoking dependency

186

2.66

9.18

1.1

22.02

21.52

u/l

0.03

168

Mental and behavioural disorders due to tobacco

186

2.66

9.18

1.1

22.02

21.31

u/l

0.04

168

Depression or dysthymia

272

976

1.52

9.08

1.2

21.17

23.45

u/l

0.32

240

882

Pruritus

265

2.35

9.05

1.2

1.1

20.28

21.57

u/l

0.12

236

Concussion

193

923

1.62

9.03

1.2

1.1

22.19

20.64

u/l

0.14

162

833

Benign neoplasms

374

1427

1.43

9.02

1.2

1.1

28.06

22.14

u/l

0.74

334

1274

Mood [affective] disorders

419

1933

1.39

8.94

1.2

1.1

22.75

23.29

u/l

0.06

369

1735

Candidiasis

330

2.19

8.92

1.2

30.29

21.79

u/l

0.51

296

Mood disorders

420

1936

1.39

8.91

1.2

1.1

22.72

23.27

u/l

0.06

370

1738

Excessive earwax

277

1695

1.48

8.88

1.1

22.61

24.77

u/l

0.26

243

1503

Hypoglycaemia, other or unspecified

128

2.99

8.88

1.3

1.2

22.92

22.04

u/l

0.05

114

Exposure to other specified factors

332

1990

1.43

8.87

1.2

1.1

23.67

22.61

u/l

0.12

291

1785

Other general symptoms and signs

3.63

8.85

1.1

12.72

20.18

u/l

0.73

Gonarthrosis

270

1010

1.51

8.79

1.1

25.79

24.12

u/l

0.13

238

901

Benign neoplasm of colon, rectum, anus and anal canal

285

1637

1.47

8.79

1.2

1.1

27.24

24.49

u/l

0.37

253

1446

Hypopituitarism

114

3.09

8.65

1.2

60.97

20.80

u/l

0.57

105

Disease of hard tissues of teeth, NOS

219

725

1.58

8.60

1.2

1.1

21.40

28.27

u/l

0.88

190

648

All influenza (not pneumonia)

265

2.31

8.59

1.3

1.1

27.72

23.20

u/l

0.26

240

Other CVD

514

1.92

8.44

1.1

30.87

27.75

u/l

0.14

447

Disorders of sclera, cornea, iris and ciliary body

232

1533

1.52

8.43

1.1

20.25

23.83

u/l

0.63

212

1366

Polyarthrosis

106

511

1.88

8.43

1.2

1.1

24.31

23.58

u/l

0.06

451

Postprocedural endocrine and metabolic disorders, not elsewhere classified

288

2.24

8.32

1.1

1.2

32.33

16.86

u/l

0.40

264

Other respiratory disorders and diseases

504

1.91

8.26

1.1

33.48

29.04

u/l

0.29

439

Other diseases of the respiratory system

504

1.91

8.26

1.1

33.48

29.04

u/l

0.29

439

Diverticular disease of intestine

301

1292

1.45

8.21

1.2

1.1

20.91

23.98

u/l

0.55

258

1151

Fibromyalgia

209

2.46

8.21

1.3

1.1

14.00

18.40

u/l

0.76

192

Viral and other specified intestinal infections, including avohilmo

505

1.89

8.20

1.3

1.2

26.79

18.85

u/l

0.45

454

Internal derangement of knee

156

938

1.65

8.14

1.2

17.08

23.56

u/l

1.87

149

839

Diseases of the musculoskeletal system and connective tissue

178

543

1.65

8.11

1.2

1.1

17.72

21.00

u/l

0.55

161

482

Pacemaker

158

896

1.64

8.03

1.1

29.65

27.54

u/l

0.21

138

768

Congenital malformations, deformations and chromosomal abnormalities

225

1413

1.51

8.02

1.2

1.1

23.29

22.51

u/l

0.07

207

1273

Injuries to the elbow and forearm

300

1799

1.43

7.99

1.2

1.1

22.09

23.42

u/l

0.22

262

1611

Other skin changes

518

1.88

7.95

1.2

1.1

38.16

25.35

u/l

0.78

452

Abnormalities of heart beat

149

873

1.66

7.92

1.1

20.84

23.68

u/l

0.37

136

781

Conduction disorders

122

555

1.77

7.88

1.1

27.29

22.38

u/l

0.68

109

486

Cystitis

347

1471

1.40

7.85

1.1

20.12

24.21

u/l

1.10

311

1320

Adalimumab

190

2.49

7.80

1.1

21.27

18.95

u/l

0.09

176

Pain associated with micturition

271

2.23

7.76

1.2

1.1

13.84

23.20

u/l

2.55

246

Bronchitis

441

1966

1.35

7.73

1.2

1.1

24.75

22.74

u/l

0.38

397

1749

Psoriasis vulgaris

439

1.95

7.71

1.2

1.1

22.70

24.20

u/l

0.08

395

Abnormal spermatozoa

234

2.32

7.70

1.2

1.1

18.69

39.77

u/l

2.62

206

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

327

2.09

7.68

1.2

1.1

19.77

24.79

u/l

0.47

293

Retention of urine

137

656

1.69

7.65

1.1

36.88

24.91

u/l

0.92

119

581

Symptoms and signs involving the nervous and musculoskeletal systems

246

1680

1.47

7.64

1.2

1.1

25.00

22.56

u/l

0.19

218

1488

Rheumatism, unspecified

352

2.06

7.63

1.1

19.65

19.68

u/l

0.00

313

Factors influencing health status and contact with health services

230

1.99

7.62

1.2

1.1

24.33

20.76

u/l

0.30

202

Acute pancreatitis (for exclusion)

462

1.91

7.61

1.2

1.1

47.06

26.45

u/l

0.72

410

Neurotic, stress-related and somatoform disorders

355

1770

1.38

7.54

1.2

1.1

27.75

21.52

u/l

0.73

322

1590

Benign neoplasm: Colon

240

1534

1.47

7.51

1.2

1.1

27.68

24.25

u/l

0.43

217

1347

Acute sinusitis

209

1259

1.51

7.45

1.1

19.27

23.05

u/l

0.73

192

1125

Non-selective monoamine reuptake inhibitors

168

1020

1.58

7.44

1.1

19.52

26.94

u/l

1.26

144

908

Malignant neoplasm of digestive organs, including Hilmo

163

745

1.61

7.43

1.1

35.71

21.49

u/l

2.28

153

636

Other diseases of hard tissues of teeth

216

731

1.53

7.42

1.1

26.23

28.25

u/l

0.18

200

653

Caries of dentine, including avohilmo

301

1076

1.43

7.38

1.1

24.74

23.91

u/l

0.08

277

965

Disorders of eyelid, lacrimal system and orbit

363

1943

1.37

7.38

1.2

1.1

20.92

23.69

u/l

0.54

329

1721

Disorders of continuity of bone

202

2.39

7.33

1.3

1.1

31.50

17.78

u/l

0.48

183

Other disorders of lacrimal gland

173

1112

1.56

7.22

1.2

1.1

18.26

23.95

u/l

1.32

157

993

Chronic gastritis

118

690

1.72

7.18

1.1

19.38

26.64

u/l

1.61

102

607

Biguanides

391

1744

1.35

7.18

1.1

1.2

25.49

22.51

u/l

0.47

346

1561

Coxarthrosis

211

901

1.51

7.18

1.1

24.82

23.68

u/l

0.12

180

804

Use of hypnotics and sedatives

426

1821

1.34

7.14

1.2

1.1

25.40

22.97

u/l

0.38

376

1629

Anxiety disorders

356

1786

1.37

7.13

1.2

1.1

27.69

21.70

u/l

0.70

323

1603

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

304

2.08

7.11

1.2

1.1

20.40

23.78

u/l

0.27

272

Keratitis

150

939

1.60

7.02

1.1

19.18

25.41

u/l

1.38

139

833

Symptoms and signs involving the skin and subcutaneous tissue

300

2036

1.39

7.01

1.2

1.1

24.93

23.18

u/l

0.22

279

1799

Spondylopathies

324

1380

1.39

6.95

1.2

1.1

26.05

24.62

u/l

0.12

285

1227

Otitis externa

549

1.79

6.94

1.1

24.97

23.33

u/l

0.08

490

Pulmonary heart disease, diseases of pulmonary circulation

138

849

1.63

6.94

1.2

1.1

40.07

23.98

u/l

2.09

128

735

Dysphagia

103

586

1.76

6.92

1.2

1.1

24.04

23.77

u/l

0.02

520

Hypotension

407

1.92

6.91

1.1

33.63

28.49

u/l

0.19

355

Pleural effusion

366

1.98

6.89

1.1

46.31

28.14

u/l

1.20

318

Early onset COPD, excluding more controls

421

1.91

6.89

1.2

1.1

22.60

23.17

u/l

0.04

364

Polycystic ovarian syndrome, consortium definition

303

1239

1.41

6.88

1.2

1.1

17.00

20.44

u/l

0.92

272

1113

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

101

566

1.77

6.83

1.2

1.1

15.61

21.05

u/l

1.35

512

Other diseases of upper respiratory tract

438

1724

1.32

6.77

1.2

1.1

19.18

24.71

u/l

1.03

385

1538

Substance abuse, excluding more controls

209

1179

1.48

6.77

1.1

1.2

39.08

21.23

u/l

1.52

176

1059

Other gastritis (incl. Duodenitis)

518

1.80

6.73

1.2

1.1

34.10

26.81

u/l

0.39

455

Examination and observation for other reasons

192

709

1.53

6.72

1.2

1.1

28.50

22.44

u/l

0.52

178

614

Degeneration of macula and posterior pole

207

1076

1.49

6.71

1.2

1.1

26.05

23.75

u/l

0.34

178

938

Symptoms and signs involving cognition, perception, emotional state and behaviour

388

1941

1.34

6.68

1.1

25.65

22.80

u/l

0.38

342

1736

Abnormal weight loss

205

2.31

6.66

1.0

1.2

19.26

26.10

u/l

0.73

179

Malignant neoplasm of skin

191

854

1.52

6.64

1.2

1.1

25.65

21.19

u/l

0.65

173

731

Disorders of skin appendages

195

1304

1.49

6.63

1.1

1.2

22.25

23.07

u/l

0.07

184

1165

Primary gonarthrosis, bilateral

235

1366

1.44

6.61

1.1

24.65

24.23

u/l

0.05

200

1210

Alcohol use disorder, Swedish definition

205

1263

1.48

6.60

1.1

1.2

41.38

22.30

u/l

1.55

177

1130

Dorsalgia

377

1483

1.35

6.59

1.2

1.1

18.66

23.89

u/l

1.55

336

1321

Diseases of oral cavity, salivary glands and jaws

213

736

1.49

6.54

1.1

21.36

28.23

u/l

1.32

195

657

Other (seronegative) rheumatoid arthritis, wide

494

1.81

6.54

1.1

19.83

24.53

u/l

0.87

434

Fracture of foot, except ankle

104

605

1.72

6.50

1.3

1.2

20.23

20.05

u/l

0.02

549

Respiratory insufficiency

152

2.51

6.46

1.1

22.39

23.31

u/l

0.05

129

Benign neoplasm of other and ill-defined parts of digestive system

467

1.83

6.46

1.1

22.17

27.02

u/l

0.68

415

Postprocedural musculoskeletal disorders, not elsewhere classified

165

2.44

6.43

1.2

18.53

23.55

u/l

0.32

146

Any death

268

1335

1.41

6.38

1.2

1.1

58.13

18.81

u/l

6.62

249

1172

Arthrosis

272

1057

1.41

6.34

1.1

26.33

23.41

u/l

0.24

241

947

Cerebrovascular diseases

302

1525

1.38

6.30

1.2

1.1

38.07

23.08

u/l

1.92

266

1352

Gingivitis and periodontal diseases

387

1502

1.33

6.24

1.1

19.16

26.16

u/l

2.40

346

1339

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

387

1850

1.32

6.20

1.2

1.1

24.23

23.22

u/l

0.16

346

1652

Polyp of the female genital tract

139

488

1.62

6.19

1.2

1.1

22.66

22.01

u/l

0.05

117

443

Disorders of lacrimal system

198

1333

1.46

6.19

1.2

1.1

19.06

24.54

u/l

1.31

181

1185

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

242

1562

1.41

6.18

1.2

1.1

23.41

21.97

u/l

0.16

223

1399

Malignant neoplasm of skin, including Hilmo

197

892

1.48

6.16

1.2

1.1

26.27

21.09

u/l

0.84

179

765

Other local infections of skin and subcutaneous tissue

220

2.19

6.08

1.1

44.14

22.66

u/l

0.52

198

Undetermined asthma, excluding more controls

259

2.09

6.08

1.1

17.53

18.23

u/l

0.06

225

Other diseases of oesophagus

176

2.34

6.05

1.1

1.2

46.52

35.16

u/l

0.14

160

Myalgia

100

588

1.71

6.05

1.1

23.25

21.66

u/l

0.10

522

Hypertensive Heart Disease

401

1.76

6.04

1.1

32.63

20.68

u/l

1.18

346

Selective serotonin reuptake inhibitors

378

1481

1.33

6.01

1.2

19.69

25.31

u/l

1.48

330

1323

Mycoses, including avohilmo

362

2085

1.32

5.98

1.1

24.45

22.86

u/l

0.21

316

1867

Other external causes of accidental injury

304

1110

1.37

5.97

1.2

1.1

24.67

22.03

u/l

0.32

269

1006

Open wound of head

215

1412

1.43

5.96

1.1

26.11

22.72

u/l

0.56

181

1264

225

1378

1.42

5.94

1.1

1.2

40.62

22.29

u/l

1.66

194

1232

Fracture of rib(s), sternum and thoracic spine

127

798

1.60

5.94

1.1

26.65

26.59

u/l

0.00

113

698

Infective dermatitis

236

2.13

5.90

1.1

52.64

29.25

u/l

0.58

214

Gonarthrosis, primary, with knee surgery

254

1422

1.39

5.86

1.1

25.61

23.92

u/l

0.23

222

1260

Alcohol-induced chronic pancreatitis

107

2.73

5.85

1.1

1.2

52.30

28.04

u/l

0.54

100

Accidents

303

1110

1.37

5.84

1.2

1.1

24.72

22.03

u/l

0.33

269

1006

Kela reimbursement Agammaglobulinemia (D80-84)

9.44

5.83

1.7

1.1

41.82

13.22

u/l

1.74

Other malignant neoplasms of skin (=non-melanoma skin cancer)

172

779

1.50

5.78

1.2

1.1

24.73

22.04

u/l

0.31

153

661

Gonarthrosis,primary

372

1704

1.32

5.78

1.1

24.73

23.38

u/l

0.14

325

1521

Calcific aortic valvular stenosis

120

720

1.61

5.77

1.1

38.93

28.95

u/l

0.44

105

622

Calcific aortic valvular stenosis, operated

120

720

1.61

5.77

1.2

1.1

38.93

28.95

u/l

0.44

105

622

Operations 2 for CAVS

120

720

1.61

5.77

1.2

1.1

38.93

28.95

u/l

0.44

105

622

Calcific aortic valvular stenosis, diagnosis (helper)

120

720

1.61

5.77

1.2

1.1

38.93

28.95

u/l

0.44

105

622

Calcific aortic valvular stenosis, including rheumatic fever

120

720

1.61

5.75

1.2

1.1

38.93

28.95

u/l

0.44

105

622

Injuries to the ankle and foot

276

1728

1.37

5.74

1.2

1.1

22.83

21.41

u/l

0.16

243

1556

Fracture of forearm

234

1502

1.40

5.73

1.2

1.1

23.03

24.00

u/l

0.13

206

1342

Urticaria and erythema

146

955

1.53

5.73

1.2

1.1

25.63

21.85

u/l

0.42

135

849

Stroke, excluding SAH

241

1243

1.40

5.71

1.1

42.51

22.49

u/l

2.11

205

1100

External causes of morbidity and mortality

236

832

1.42

5.71

1.2

1.1

19.88

21.67

u/l

0.26

211

745

Asthma-related infections

232

1618

1.40

5.71

1.1

25.55

24.28

u/l

0.13

212

1430

Asthma, hospital admission 2, infections

232

1618

1.40

5.71

1.1

25.55

24.28

u/l

0.13

212

1430

Infliximab

4.79

5.63

1.3

1.2

10.12

27.69

u/l

1.17

Exclusions for E4_PCOS_CONSORTIUM

286

1311

1.36

5.62

1.2

1.1

25.02

20.58

u/l

0.44

262

1175

Substance use, excluding alcohol

416

1.81

5.58

1.2

1.1

20.89

21.82

u/l

0.07

379

Stroke, including SAH

256

1332

1.38

5.58

1.1

40.99

23.46

u/l

1.88

220

1183

Dental caries, including avohilmo

273

1014

1.38

5.57

1.1

25.58

24.17

u/l

0.13

250

911

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

176

803

1.48

5.56

1.2

1.1

24.73

21.64

u/l

0.39

159

683

Injuries to the thorax

180

1237

1.46

5.55

1.2

1.1

24.78

24.89

u/l

0.01

161

1088

Uterine polyps

130

478

1.59

5.54

1.1

28.91

21.81

u/l

0.55

107

433

Diagnoses used for exclusion with ILD

103

629

1.64

5.45

1.1

31.31

24.69

u/l

0.67

552

COPD (mode)

115

558

1.61

5.42

1.2

1.1

21.08

22.52

u/l

0.16

479

L01XE Protein kinase inhibitors

106

2.66

5.41

1.1

69.04

25.62

u/l

1.74

Pulmonary embolism

122

779

1.57

5.37

1.2

1.1

40.53

24.28

u/l

1.82

115

677

Other problems related to primary support group, including family circumstances

193

2.18

5.37

1.2

10.76

18.15

u/l

2.13

180

Polymyalgia rheumatica

301

1.94

5.33

1.1

40.09

24.13

u/l

0.62

257

Mental and behavioural disorders due to psychoactive substance use

219

1438

1.40

5.31

1.1

1.2

38.61

22.18

u/l

1.44

185

1289

Undetermined asthma

274

1.98

5.27

1.1

17.53

23.52

u/l

0.62

240

Pulmonary heart disease

122

783

1.56

5.26

1.2

1.1

40.53

24.41

u/l

1.80

115

681

Follow-up examination after treatment for malignant neoplasms

214

2.11

5.25

1.1

18.56

24.51

u/l

0.70

180

Aortic valve malfunction, age under 60 years

188

2.19

5.24

1.2

1.1

51.44

24.41

u/l

0.52

173

Primary coxarthrosis, bilateral

124

800

1.55

5.24

1.2

1.1

23.92

25.90

u/l

0.17

107

705

Other and unspecified urticaria

447

1.75

5.23

1.2

24.56

18.34

u/l

0.59

398

Other abnormal uterine and vaginal bleeding

104

457

1.64

5.20

1.2

1.1

21.38

22.27

u/l

0.08

414

Acute upper respiratory infections of multiple and unspecified sites

294

1609

1.33

5.19

1.2

1.1

22.68

23.61

u/l

0.13

271

1433

Systemic sclerosis

3.52

5.19

1.2

22.00

26.60

u/l

0.25

Venous thromboembolism

218

1513

1.39

5.18

1.2

1.1

32.58

23.74

u/l

1.45

201

1336

Moderate visual impairment, binocular

3.37

5.17

1.3

1.1

28.61

24.68

u/l

0.11

Psychiatric diseases

371

1430

1.30

5.13

1.2

1.1

28.76

21.30

u/l

0.96

337

1282

Ischaemic Stroke, excluding all haemorrhages

222

1177

1.39

5.10

1.1

40.61

22.87

u/l

1.69

188

1036

Shoulder lesions

285

1274

1.34

5.07

1.2

1.1

23.91

24.32

u/l

0.04

260

1128

DVT of lower extremities and pulmonary embolism

169

1165

1.45

5.07

1.2

1.1

35.90

25.26

u/l

1.39

159

1016

Contact with and exposure to communicable diseases

600

1.63

5.06

1.2

20.84

16.61

u/l

0.32

549

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

328

1.87

5.05

1.2

1.1

17.15

19.16

u/l

0.22

302

Injuries to the head

427

1997

1.27

5.05

1.1

1.2

28.18

21.76

u/l

0.86

354

1806

Other diseases of intestine

357

1.83

5.04

1.1

22.79

26.49

u/l

0.35

316

208

1334

1.39

5.01

1.1

1.2

39.53

22.31

u/l

1.49

179

1195

Type 1 diabetes, strict (exclude DM2)

116

2.50

5.00

1.1

19.04

14.78

u/l

0.34

109

Diseases of pulp and periapical tissues and dental caries

239

888

1.38

4.98

1.1

1.2

23.75

24.69

u/l

0.09

219

798

Personality disorders, excluding more controls

506

1.68

4.95

1.2

1.1

32.75

20.53

u/l

0.37

457

Excessive attrition of teeth

233

1695

1.36

4.94

1.1

1.2

19.27

22.96

u/l

0.84

206

1518

Type 1 diabetes, definitions combined

117

2.48

4.91

1.1

19.04

14.98

u/l

0.32

110

Substance abuse

209

1404

1.38

4.87

1.1

1.2

39.08

22.41

u/l

1.37

176

1260

Superficial injury of hip and thigh

325

1.85

4.87

1.3

1.1

22.87

24.44

u/l

0.11

297

Other/unspecified rheumatoid arthritis

297

1.89

4.86

1.1

1.2

22.65

25.69

u/l

0.33

263

Malignant melanoma, including Hilmo

376

1.79

4.86

1.3

1.1

26.23

23.90

u/l

0.17

321

Nonhereditary hypogammaglobulinemia

5.85

4.78

1.7

1.1

38.42

16.08

u/l

1.27

Somatoform disorder

372

1.78

4.73

1.1

23.90

19.52

u/l

0.21

335

Basal cell carcinoma, including Hilmo

167

784

1.44

4.72

1.2

1.1

23.78

21.95

u/l

0.20

150

665

Carpal tunnel syndrome

249

1611

1.34

4.71

1.2

1.1

25.37

23.42

u/l

0.20

222

1432

Intracranial injury

221

1512

1.36

4.71

1.2

1.1

25.85

22.28

u/l

0.36

186

1356

Myocardial infarction, unclassifiable

431

1.68

4.69

1.1

51.96

27.95

u/l

0.94

375

Status epilepticus

3.13

4.64

1.2

24.44

31.06

u/l

0.30

Obesity related asthma

140

953

1.47

4.64

1.1

16.91

25.74

u/l

2.63

127

850

Benign paroxysmal vertigo

127

848

1.50

4.63

1.1

21.95

24.70

u/l

0.27

118

748

Systemic sclerosis, icd10

3.25

4.63

1.2

22.00

28.06

u/l

0.35

Haemorrhoids and perianal venous thrombosis

134

898

1.48

4.62

1.2

1.1

25.22

23.93

u/l

0.12

124

795

Asthma-related pneumonia

143

975

1.46

4.61

1.1

30.44

25.55

u/l

0.44

131

852

Asthma-related pneumonia or sepsis

143

975

1.46

4.61

1.1

30.44

25.55

u/l

0.44

131

852

Asthma, hospital admissions 3, pneumonia

143

975

1.46

4.61

1.1

30.44

25.55

u/l

0.44

131

852

166

1159

1.42

4.60

1.2

1.1

23.31

24.04

u/l

0.07

153

1028

Acute and subacute iridocyclitis

450

1.69

4.59

1.2

1.1

22.30

24.63

u/l

0.13

402

Fissure and fistula of anal and rectal regions

557

1.62

4.58

1.1

18.39

23.26

u/l

0.81

497

Colectomy operation

413

1.73

4.58

1.2

1.1

30.87

29.27

u/l

0.07

367

Glucagon-like peptide-1 (GLP-1) analogues

123

818

1.51

4.58

1.1

1.2

22.97

23.88

u/l

0.10

108

739

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

123

818

1.51

4.58

1.1

1.2

22.97

23.88

u/l

0.10

108

739

Bacterial, viral and other infectious agents

141

2.28

4.54

1.3

1.2

41.75

21.52

u/l

0.63

130

Left ventricular outflow tract obstruction (LVOTO), broad definition

200

2.06

4.53

1.2

1.1

51.44

24.27

u/l

0.52

183

121

688

1.51

4.51

1.2

1.1

26.96

27.41

u/l

0.04

103

595

Other other unspecified disorders of the circulatory system

2.88

4.50

1.1

1.2

22.15

23.08

u/l

0.05

Ventral hernia

631

1.57

4.48

1.2

1.1

25.73

25.49

u/l

0.01

554

severe traumatic brain injury, does not include concussion

522

1.63

4.47

1.2

1.1

32.00

28.84

u/l

0.16

460

Malignant melanoma

336

1.79

4.42

1.3

1.1

26.23

22.08

u/l

0.32

287

Persons with potential health hazards related to communicable diseases

122

809

1.50

4.41

1.2

21.05

19.16

u/l

0.15

100

741

Suppurative and unspecified otitis media

112

651

1.53

4.37

1.2

31.52

20.33

u/l

0.70

107

586

Colorectal cancer, including Hilmo

562

1.58

4.34

1.1

31.13

23.54

u/l

0.75

477

Common variable immunodeficiency

9.16

4.31

2.0

1.1

54.00

15.86

u/l

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

568

1.59

4.28

1.2

19.26

19.15

u/l

0.01

517

Iridocyclitis

552

1.60

4.28

1.2

1.1

21.47

24.42

u/l

0.20

489

Hernia of abdominal wall

170

1220

1.40

4.26

1.2

1.1

29.78

24.96

u/l

0.38

159

1080

Other viral diseases

631

1.55

4.19

1.2

26.31

20.50

u/l

0.78

570

Traumatic subdural haemorrhage

278

1.82

4.18

1.1

37.62

22.86

u/l

0.72

239

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

101

658

1.54

4.17

1.2

15.61

19.98

u/l

1.03

602

Disorders of conjunctiva

316

1919

1.28

4.17

1.2

1.1

19.51

23.78

u/l

0.90

297

1701

Chronic periodontitis, complicated

226

1660

1.33

4.14

1.2

1.1

18.28

25.20

u/l

2.76

200

1481

Anxiety (asthma-related co-morbidities)

213

1204

1.35

4.12

1.2

27.95

19.74

u/l

0.63

190

1094

Flat foot [pes planus] (acquired)

229

1.93

4.10

1.2

1.1

19.64

21.24

u/l

0.13

205

Asthma (diagnoses ohter than nonallergic)

329

2100

1.27

4.09

1.1

1.2

19.49

23.83

u/l

1.19

299

1866

Speech and linguistic disorders, excluding more controls

2.48

4.07

1.2

13.74

18.79

u/l

0.41

Diseases of inner ear

219

1576

1.33

4.06

1.1

22.45

24.70

u/l

0.27

203

1391

Provisional assignment of new diseases of uncertain etiology

198

1456

1.35

4.06

1.2

1.1

31.31

22.92

u/l

1.39

182

1281

Codes for special purposes

198

1457

1.35

4.04

1.2

1.1

31.31

22.91

u/l

1.40

182

1282

Alzheimer’s disease, strict definition

565

0.51

4.00

1.1

42.16

28.87

u/l

0.50

484

Artificial joint operation, meniscal resection

357

1822

1.25

3.97

1.1

21.48

24.90

u/l

0.75

313

1628

Other disorders of the musculoskeletal system and connective tissue

363

1.71

3.96

1.2

24.02

26.33

u/l

0.15

325

Attention to artificial openings

2.83

3.96

1.0

1.2

40.83

28.38

u/l

0.18

Infections with a predominantly sexual mode of transmission

102

673

1.52

3.95

1.2

34.68

17.72

u/l

1.15

619

Benign neoplasm: Colon, unspecified

102

675

1.52

3.95

1.1

32.22

27.11

u/l

0.40

591

L02BA Anti-estrogens

470

1.62

3.95

1.2

20.21

20.76

u/l

0.04

418

Other hearing loss

107

692

1.50

3.95

1.3

1.1

34.63

27.07

u/l

0.44

592

Injuries to the knee and lower leg

445

1962

1.23

3.94

1.1

1.2

23.43

22.68

u/l

0.10

397

1748

518

1.57

3.93

1.2

1.1

25.93

29.14

u/l

0.30

448

167

1089

1.38

3.92

1.2

1.1

25.85

25.80

u/l

0.00

149

946

Irregular menses

189

1046

1.36

3.91

1.2

1.1

16.26

17.76

u/l

0.23

175

945

Obesity, other/unspecified

125

864

1.45

3.90

1.1

18.23

21.78

u/l

0.62

116

785

Other neurological diseases

279

1686

1.28

3.90

1.1

27.66

24.12

u/l

0.32

249

1489

Basal cell carcinoma

158

769

1.40

3.90

1.2

1.1

23.63

22.18

u/l

0.14

141

652

L02BB Anti-androgens

178

2.03

3.88

1.3

1.1

35.54

35.20

u/l

0.01

157

Alzheimer disease

690

0.59

3.88

1.1

39.07

28.12

u/l

0.62

589

Anterior Iridocyclitis

488

1.60

3.87

1.2

1.1

21.83

24.04

u/l

0.13

434

Disorders of vestibular function (Vertigo)

190

1375

1.35

3.86

1.1

23.86

24.01

u/l

0.01

177

1220

Artrosis, including avohilmo

301

1289

1.28

3.86

1.1

19.74

25.32

u/l

1.45

270

1161

Unspecified fall

193

1411

1.34

3.86

1.2

1.1

25.79

24.42

u/l

0.11

169

1250

Procreative management

122

689

1.46

3.86

1.2

19.63

19.99

u/l

0.03

108

623

Fracture of lower leg, including ankle

213

1582

1.32

3.83

1.2

1.1

27.24

23.84

u/l

0.26

186

1406

Alzheimer disease, including avohilmo

786

0.62

3.82

1.1

33.22

27.56

u/l

0.35

668

Other or unspecified common variable immunodeficiency

12.51

3.80

2.3

1.0

51.67

22.34

u/l

—

SLE (Finngen)

2.86

3.80

1.1

18.59

27.62

u/l

0.59

Malignant neoplasm of digestive organs

131

698

1.44

3.78

1.1

37.75

21.76

u/l

2.08

123

594

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

192

1383

1.34

3.77

1.1

1.2

22.05

24.00

u/l

0.11

169

1238

Actinic keratosis

154

1013

1.39

3.70

1.2

1.1

27.39

25.83

u/l

0.15

137

873

Amputation of thigh

3.62

3.70

1.2

1.1

31.21

46.34

u/l

0.53

Suicide or other Intentional self-harm

557

1.55

3.70

1.2

16.73

20.94

u/l

0.80

504

Glaucoma

228

1484

1.31

3.69

1.2

1.1

20.00

26.34

u/l

1.71

190

1319

Sequelae of cerebrovascular disease

140

850

1.41

3.69

1.2

1.1

35.69

25.01

u/l

0.94

125

742

Other noninflammatory disorders of vulva and perineum

224

1.88

3.67

1.4

1.1

20.65

17.68

u/l

0.28

205

Benign thyroid growths and nodules

134

882

1.41

3.65

1.1

15.93

25.19

u/l

3.62

121

792

Spinal stenosis

205

1140

1.33

3.64

1.2

1.1

24.98

25.01

u/l

0.00

182

1011

Presbycusis

308

1.74

3.64

1.1

21.22

33.39

u/l

1.65

253

Enthesopathies of lower limb, excluding foot

616

1.51

3.62

1.2

1.1

25.20

24.11

u/l

0.06

554

Alzheimer’s disease (Late onset)

513

0.51

3.61

1.1

43.67

29.19

u/l

0.48

435

Adjustment and management of implanted device

381

1.66

3.60

1.0

1.1

28.75

28.67

u/l

0.01

326

Poisoning by medicine

459

1.59

3.58

1.2

1.1

17.61

19.44

u/l

0.20

417

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

252

1.81

3.58

1.2

1.1

27.20

25.66

u/l

0.09

210

Skin changes due to chronic exposure to nonionizing radiation

157

1038

1.37

3.57

1.2

1.1

26.91

26.07

u/l

0.08

140

898

Urticaria

109

748

1.46

3.57

1.2

1.1

26.68

21.41

u/l

0.51

669

Fall on same level involving ice and snow

223

1719

1.30

3.54

1.2

1.1

25.31

23.73

u/l

0.14

197

1533

Asthma, including avohilmo

438

1989

1.21

3.54

1.1

1.2

20.86

23.84

u/l

0.65

402

1764

All anxiety disorders

216

1281

1.31

3.54

1.2

28.02

19.44

u/l

0.69

193

1156

Dermatophytosis

316

1.71

3.50

1.1

24.98

27.25

u/l

0.13

286

Heartburn

228

1.85

3.49

1.2

17.14

22.74

u/l

0.39

204

Other hammer toe(s) (acquired)

413

1.59

3.45

1.2

1.1

19.46

22.45

u/l

0.43

365

Specific personality disorders

495

1.56

3.45

1.2

34.50

18.78

u/l

0.43

451

Other dorsopathies, not elsewhere classified

354

1487

1.24

3.44

1.2

1.1

20.56

23.83

u/l

0.71

319

1325

Ill-defined and unknown causes of mortality

208

1.88

3.43

1.1

25.97

32.39

u/l

0.46

183

Degenerative diseases of the nervous system

777

0.64

3.43

1.1

35.32

28.15

u/l

0.46

662

Open wound of forearm

180

1.95

3.42

1.2

1.1

24.79

25.16

u/l

0.02

162

Atopic dermatitis, strict definition with reimbursement

599

1.49

3.41

1.2

1.1

17.89

18.77

u/l

0.07

546

Unspecified contracted kidney

7.19

3.39

1.1

1.3

73.71

19.37

u/l

—

Other/unspecified dorsalgia

143

1029

1.37

3.36

1.1

18.74

23.29

u/l

0.80

126

912

Other/unspecified synovitis and tenosynovitis

253

1.79

3.36

1.0

1.1

35.17

24.38

u/l

0.29

228

Other headache syndromes

152

1116

1.36

3.34

1.2

1.1

20.64

23.24

u/l

0.40

140

1001

Bacterial, viral and other infectious agents, including avohilmo

161

2.00

3.33

1.3

1.2

41.75

21.51

u/l

0.63

148

Other diseases of lip and oral mucosa

165

1232

1.34

3.33

1.2

1.1

20.16

23.75

u/l

0.72

147

1105

Striking against or struck by other objects

108

750

1.44

3.32

1.2

32.76

24.56

u/l

0.50

671

Bipolar affective disorders

375

1.63

3.30

1.3

1.2

37.84

18.74

u/l

0.47

339

Coxarthrosis, primary

238

1548

1.28

3.30

1.1

23.08

25.81

u/l

0.40

205

1369

Unspecific neurodegenerative disorder

894

0.68

3.23

1.1

24.65

26.34

u/l

0.14

764

264

1.75

3.22

1.2

1.1

57.77

21.05

u/l

0.71

240

Nail disorders

185

1.90

3.19

1.1

1.2

43.89

22.12

u/l

0.57

169

Diplopia

310

1.68

3.18

1.2

1.1

21.95

25.08

u/l

0.22

277

Visual disturbances and blindness

200

1545

1.29

3.17

1.2

1.1

24.76

23.18

u/l

0.10

182

1369

Temporomandibular joint disorders, including avohilmo

161

1170

1.33

3.15

1.2

21.80

19.65

u/l

0.21

142

1061

Unspecified mental disorder

134

978

1.37

3.15

1.2

1.1

14.77

24.96

u/l

3.37

117

884

Coxarthrosis, primary, with hip surgery

186

1322

1.31

3.12

1.1

22.75

25.88

u/l

0.41

161

1166

Inflammatory diseases of female pelvic organs

245

1324

1.27

3.12

1.2

1.1

19.47

19.68

u/l

0.03

210

1197

3.46

3.11

1.2

1.1

25.75

26.68

u/l

0.03

Cardiodefibrillation

128

927

1.38

3.11

1.1

27.27

28.57

u/l

0.09

103

811

Colonic or urogenital fistula

671

1.45

3.10

1.1

20.91

25.07

u/l

0.52

603

Barrett oesophagus

2.34

3.08

1.1

1.2

13.50

29.88

u/l

1.80

Duodenal ulcer

217

1.80

3.04

1.1

21.00

32.98

u/l

0.83

192

Polyuria

535

1.50

3.04

1.1

17.32

25.33

u/l

1.96

472

Mental and behavioural disorders due to alcohol

169

1223

1.32

3.04

1.1

1.2

42.95

22.69

u/l

1.38

143

1098

Kela-code for severe mental illness

120

868

1.38

3.00

1.2

1.1

15.07

25.82

u/l

3.09

103

783

Fall on and from stairs and steps

660

1.44

2.99

1.1

18.52

24.43

u/l

1.09

584

Open wound of lower leg

332

1.63

2.96

1.1

57.60

26.57

u/l

0.91

296

Personality disorders

579

1.47

2.96

1.2

32.75

18.62

u/l

0.45

527

Nonorganic sleeping disorders, excluding more controls

418

1.56

2.96

1.2

1.1

26.87

23.00

u/l

0.16

378

Delirium, not induced by alcohol and other psychoactive substances

278

1.69

2.96

1.2

1.1

23.86

28.84

u/l

0.45

249

Sulfonylureas

120

688

1.39

2.95

1.1

35.40

25.36

u/l

0.86

103

597

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

162

1.93

2.95

1.2

17.17

21.56

u/l

0.45

147

Dorsopathies

357

1490

1.21

2.94

1.2

1.1

22.33

23.79

u/l

0.21

318

1328

Other embolism and thrombosis

295

1.67

2.92

1.2

1.1

32.54

23.35

u/l

0.73

266

Spontaneous rupture of synovium and tendon

184

1.86

2.91

1.1

1.2

32.93

26.75

u/l

0.15

164

Epilepsy

102

720

1.41

2.90

1.1

25.88

24.32

u/l

0.10

633

Infection due to other mycobacteria

3.75

2.89

1.1

19.10

21.76

u/l

—

Infection due to other mycobacteria, including avohilmo

3.74

2.89

1.1

19.10

21.76

u/l

—

Factitial dermatitis

6.83

2.89

1.2

19.67

23.44

u/l

—

Microscopic polyangiitis

6.82

2.88

1.5

1.2

8.50

31.11

u/l

—

Other intervertebral disc disorders

296

1435

1.23

2.88

1.2

1.1

20.18

24.36

u/l

0.96

270

1278

Diseases of salivary glands

122

893

1.37

2.86

1.1

27.95

22.85

u/l

0.28

114

796

Other viral diseases, not elsewhere classified

374

1.58

2.83

1.2

1.1

25.34

22.91

u/l

0.18

338

Other extrapyramidal and movement disorders in other diseases

676

1.42

2.83

1.1

18.80

25.92

u/l

1.35

604

Other and unspecified disorders of vitreous body

174

1315

1.30

2.81

1.2

1.1

19.99

25.01

u/l

0.78

159

1161

Osteomyelitis of vertebra

8.61

2.77

1.2

1.3

48.00

13.67

u/l

—

Other or unspecified immunodeficiency

8.57

2.77

1.2

17.40

8.45

u/l

—

Calculus of kidney and ureter

103

738

1.40

2.76

1.2

1.1

21.97

28.02

u/l

0.70

656

Disorder of lipoprotein metabolism, unspecified

285

1.65

2.75

1.1

32.84

25.24

u/l

0.40

253

Disorder of pancreatic internal secretion, other and/or unspecified

5.10

2.74

1.0

1.2

29.14

9.98

u/l

—

Fibroblastic disorders

573

1.45

2.73

1.2

1.1

25.74

27.80

u/l

0.11

506

Care involving use of rehabilitation procedures

211

1507

1.26

2.71

1.2

1.1

26.14

20.03

u/l

1.37

183

1332

Hypertrophy of breast in women and men

533

1.47

2.71

1.1

1.2

13.29

20.87

u/l

2.54

484

Benign intracranial hypertension

6.07

2.70

1.2

1.0

8.83

33.17

u/l

—

Unspecified chronic bronchitis

2.51

2.70

1.3

1.1

28.10

31.78

u/l

—

Diaphragmatic hernia

140

1058

1.33

2.69

1.1

20.06

24.48

u/l

0.81

125

930

Disorders of breast

194

1345

1.27

2.67

1.1

17.78

20.29

u/l

0.38

173

1207

Other bursopathies

303

1.62

2.67

1.3

1.1

17.46

23.97

u/l

1.01

269

Poisoning by drugs, medicaments and biological substances

519

1.47

2.65

1.2

17.80

19.65

u/l

0.21

470

Asthma/COPD (KELA code 203)

336

1870

1.20

2.65

1.1

17.33

23.69

u/l

2.70

304

1665

Dizziness and giddiness

280

1786

1.22

2.64

1.1

27.93

22.81

u/l

0.61

242

1596

Hypertrophy of breast

479

1.49

2.64

1.1

1.2

12.23

19.35

u/l

2.77

434

Restless leg syndrome

351

1.57

2.63

1.1

17.69

23.34

u/l

0.78

314

Disorders of adult personality and behaviour

611

1.43

2.63

1.2

31.45

18.86

u/l

0.39

557

Other blood glucose lowering drugs, excl. Insulins

375

1.55

2.63

1.0

1.1

30.52

25.82

u/l

0.37

329

Pre-eclampsia or eclampsia

562

1.44

2.62

1.1

1.2

21.79

18.56

u/l

0.28

510

N06DA Anticholinesterases

790

0.68

2.61

1.0

1.1

33.13

28.05

u/l

0.29

675

Use of anticholinesterases

790

0.68

2.61

1.0

1.1

33.13

28.05

u/l

0.29

675

Colorectal cancer

523

1.45

2.60

1.1

33.99

23.66

u/l

0.92

444

COPD

161

1010

1.30

2.58

1.2

1.1

22.96

26.74

u/l

0.55

139

882

FESS (DNB20)

275

1.64

2.57

1.1

22.07

20.46

u/l

0.08

249

Unspecified acute lower respiratory infection

306

1.61

2.57

1.1

39.44

24.74

u/l

0.86

277

Severe visual impairment, binocular

7.28

2.56

1.0

1.1

15.00

21.29

u/l

—

Urolithiasis

109

800

1.36

2.56

1.2

1.1

21.23

27.32

u/l

0.76

100

707

Other viral diseases, including avohilmo

117

860

1.35

2.54

1.2

24.61

20.91

u/l

0.49

107

779

Ovarian cyst

123

520

1.35

2.53

1.2

1.1

19.37

20.88

u/l

0.16

113

472

Fracture at wrist and hand level

113

833

1.35

2.53

1.1

1.2

27.64

25.47

u/l

0.11

100

747

Superficial injury of ankle and foot

239

1.68

2.50

1.3

1.1

20.04

17.35

u/l

0.18

219

Vasomotor and allergic rhinitis

126

927

1.33

2.50

1.1

1.2

16.01

22.59

u/l

1.32

117

835

Other specified and unspecified retinal disorders

2.33

2.48

1.4

1.2

30.88

24.20

u/l

0.22

Benign neoplasm: Small intestine

2.21

2.48

1.1

1.2

21.75

22.86

u/l

0.07

Other disorders of breast

349

1.55

2.47

1.1

1.2

16.30

19.78

u/l

0.46

314

Vulvovaginal ulceration/inflammation in other diseases

137

1.91

2.45

1.1

28.73

16.33

u/l

0.98

131

Amyloidosis

2.57

2.45

1.2

109.00

26.21

u/l

0.49

Systemic lupus erythematosus

2.25

2.44

1.1

1.2

18.59

23.83

u/l

0.37

Alcohol abuse, main dg, excluding more controls

264

1.63

2.43

1.1

27.69

25.69

u/l

0.10

238

Macular pucker

415

1.50

2.42

1.2

1.1

25.77

26.64

u/l

0.06

359

Early onset COPD

563

1.42

2.42

1.2

1.1

22.60

28.77

u/l

0.66

499

In situ neoplasms

150

1164

1.29

2.42

1.2

1.1

21.62

24.12

u/l

0.43

137

1020

Schizophrenia or delusion, excluding more controls

639

1.39

2.40

1.2

16.57

21.61

u/l

0.99

576

Viral warts, including avohilmo

498

1.45

2.39

1.2

1.1

15.94

22.17

u/l

1.09

446

Dental pulpitis, including avohilmo

321

1723

1.19

2.39

1.2

18.28

23.58

u/l

1.58

286

1550

Symptoms and signs involving speech and voice

125

948

1.32

2.39

1.1

18.85

24.33

u/l

1.08

113

838

Postmenopausal bleeding

115

444

1.36

2.39

1.1

17.13

23.06

u/l

1.17

104

400

Speech and linguistic disorders

119

1.94

2.37

1.2

13.74

21.40

u/l

0.69

103

Acute lymphadenitis

2.07

2.37

1.3

1.1

68.20

23.64

u/l

0.71

Ethmoidectomy

282

1.60

2.36

1.1

22.07

21.59

u/l

0.02

255

Migraine

167

1022

1.27

2.34

1.2

16.62

20.15

u/l

0.83

157

915

Postmenopausal atrophic vaginitis

111

447

1.36

2.31

1.1

20.25

22.36

u/l

0.22

403

Dentofacial anomalies [including malocclusion]

247

1591

1.22

2.30

1.2

1.1

19.29

22.59

u/l

0.52

217

1434

Hyperplasia of prostate

103

424

1.37

2.30

1.1

1.2

19.58

32.92

u/l

2.18

375

Other chronic obstructive pulmonary disease, including avohilmo

194

1280

1.25

2.30

1.2

1.1

20.20

25.75

u/l

1.43

167

1127

Seborrhoeic keratosis

713

1.36

2.30

1.2

1.1

19.54

23.52

u/l

0.51

620

Pneumonia derived septicemia

2.39

2.29

1.1

1.2

20.29

25.17

u/l

0.27

Primary open-angle glaucoma

118

859

1.32

2.29

1.2

1.1

16.50

27.47

u/l

3.93

754

Mental and behavioural disorders due to alcohol, excluding acute intoxication

142

1094

1.29

2.27

1.2

44.57

23.11

u/l

1.17

119

981

Deforming dorsopathies

104

774

1.35

2.27

1.2

1.1

17.48

23.50

u/l

1.52

686

Other arthrosis

186

995

1.25

2.27

1.1

23.74

24.05

u/l

0.03

169

889

Unknown and unspecified causes of morbidity

120

1.92

2.25

1.2

1.1

13.39

18.95

u/l

0.74

110

Benign neoplasm: Skin, unspecified

2.16

2.25

1.4

1.2

23.82

21.09

u/l

0.10

Other symptoms and signs involving cognitive functions and awareness

174

1230

1.26

2.23

1.1

28.13

24.03

u/l

0.34

153

1089

Acute alcohol intoxication, ICD10

407

1.48

2.22

1.1

28.01

27.31

u/l

0.04

374

Cardiomyopathy in other diseases

5.65

2.22

1.2

1.0

50.00

85.44

u/l

—

Other specified disorders of external ear

2.20

2.21

1.1

1.2

63.15

28.89

u/l

0.43

Dislocation, sprain and strain of joint and ligaments of hip

2.20

2.21

1.2

1.1

46.06

22.63

u/l

0.43

Other chronic obstructive pulmonary disease

151

970

1.28

2.20

1.2

1.1

21.61

27.19

u/l

1.03

130

843

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

693

1.36

2.20

1.1

1.2

20.71

24.40

u/l

0.37

627

Infections with a predominantly sexual mode of transmission, including avohilmo

119

830

1.31

2.19

1.2

31.40

17.36

u/l

1.09

106

763

Pulmonary oedema

3.36

2.18

1.4

1.2

9.25

40.32

u/l

—

Other predominantly sexually transmitted diseases, not elsewhere classified

344

1.51

2.18

1.2

1.1

25.89

16.18

u/l

0.47

316

Benign neoplasm: Descending colon

158

1.78

2.17

1.2

1.1

28.14

27.06

u/l

0.05

138

Menorrhagia

121

511

1.32

2.17

1.2

1.1

15.30

21.27

u/l

1.50

110

465

Other and unspecified immunodeficiencies with predominantly antibody defects

3.72

2.16

1.1

1.2

43.14

27.14

u/l

—

Rotator cuff syndrome

217

1222

1.22

2.15

1.2

1.1

20.73

24.81

u/l

0.70

198

1080

Polycythaemia vera

2.31

2.15

1.1

1.2

31.57

22.88

u/l

0.30

Pollen allergy

349

1.50

2.12

1.1

1.2

12.93

16.66

u/l

0.63

318

Necrosis of pulp, including avohilmo

202

1631

1.22

2.12

1.2

16.47

22.87

u/l

2.36

180

1464

Sciatica+with lumbago

184

1317

1.24

2.11

1.1

17.23

24.50

u/l

1.69

166

1176

Disorders of ocular muscles, binocular movement, accommodation and refraction

161

1273

1.25

2.11

1.2

1.1

19.15

22.64

u/l

0.51

144

1139

Spondylosis

203

1294

1.23

2.11

1.2

1.1

27.20

25.14

u/l

0.12

172

1147

Congenital malformations and deformations of the musculoskeletal system

144

1.80

2.10

1.1

1.2

20.73

21.30

u/l

0.02

131

Wet age-related macular degeneration

421

1.45

2.10

1.1

27.11

30.16

u/l

0.22

367

Injury, poisoning and certain other consequences of external causes

173

690

1.26

2.10

1.2

1.1

21.94

21.02

u/l

0.10

155

623

Diseases of middle ear and mastoid

179

1178

1.24

2.10

1.2

1.1

31.90

22.71

u/l

0.84

170

1053

Convulsions, not elsewhere classified

432

1.44

2.09

1.1

21.09

19.35

u/l

0.16

393

Excessive, frequent and irregular menstruation

129

529

1.30

2.09

1.2

1.1

12.24

20.76

u/l

3.05

112

481

Persistent mood disorders

438

1.44

2.08

1.2

17.51

24.98

u/l

0.99

391

Mixed conductive and sensorineural hearing loss

284

1.55

2.08

1.1

19.63

27.54

u/l

0.66

247

Pre-eclampsia or poor fetal growth

101

757

1.33

2.07

1.2

19.73

17.05

u/l

0.28

690

Disturbances of skin sensation

692

1.35

2.07

1.2

1.1

17.01

21.22

u/l

0.60

620

Asthma, hospital admissions , main diagnosis only

287

2111

1.18

2.07

1.1

1.2

20.79

23.72

u/l

0.51

263

1874

Cardiomyopathy

341

1.50

2.05

1.1

24.58

24.29

u/l

0.02

297

Other immunodeficiencies

4.04

2.04

1.2

1.1

26.67

22.51

u/l

—

Unstable angina pectoris

122

740

1.30

2.03

1.1

22.36

24.37

u/l

0.27

111

633

Triptan medication for migraine, single purchase ok

263

1495

1.19

2.01

1.1

1.2

19.55

23.32

u/l

0.63

243

1341

Migraine, single triptan purchase ok & required. ICD-code if available is included

263

1495

1.19

2.01

1.1

1.2

19.55

23.32

u/l

0.63

243

1341

Other inflammation of eyelid

359

1.48

2.01

1.2

1.1

16.72

25.26

u/l

1.37

323

Conjunctivitis

264

1788

1.19

2.01

1.2

1.1

20.13

23.61

u/l

0.55

248

1591

Peritonsillar abscess

425

1.44

2.01

1.1

1.2

18.53

22.38

u/l

0.41

384

Injuries to the wrist and hand

359

2050

1.16

2.00

1.1

24.38

22.79

u/l

0.19

318

1830

Transient ischemic attack

187

1215

1.23

1.97

1.1

30.21

22.60

u/l

0.56

165

1078

SLE, ICD10

2.09

1.97

1.1

1.2

18.44

25.83

u/l

0.55

SLE, strict definition

2.09

1.97

1.1

1.2

18.44

25.83

u/l

0.55

Other obstetric conditions, not elsewhere classified

361

1.38

1.96

1.1

1.2

17.44

14.19

u/l

0.36

341

Explicit fungal Sepsis

4.61

1.95

1.0

102.60

41.55

u/l

—

Explicit fungal Sepsis, including avohilmo

4.61

1.95

1.0

102.60

41.55

u/l

—

Alcohol use disorder, ICD-based

129

1015

1.27

1.94

1.2

1.1

47.09

23.34

u/l

1.16

107

908

Melanocytic naevi, other sites/unspecified

172

1.69

1.92

1.2

1.1

15.96

20.92

u/l

0.45

157

Coronary artery bypass grafting

434

1.37

1.92

1.2

1.1

35.53

25.63

u/l

0.51

375

Benign neoplasm of eye and adnexa

259

1.55

1.89

1.1

45.35

23.14

u/l

0.76

230

Other disorders of bone

414

1.43

1.89

1.2

1.1

23.72

18.73

u/l

0.43

368

Angina pectoris

192

1045

1.22

1.88

1.1

29.53

22.25

u/l

0.73

178

918

Atrophic disorders of skin

406

1.43

1.88

1.1

18.29

20.18

u/l

0.19

360

Erosion of teeth , including avohilmo

626

1.34

1.88

1.2

24.63

20.93

u/l

0.32

569

Malignant neoplasm of corpus uteri, including Hilmo

212

1.61

1.88

1.2

1.1

20.36

20.22

u/l

0.01

179

Visual disturbances

172

1405

1.23

1.87

1.2

1.1

25.31

23.18

u/l

0.11

154

1247

Psychotic depression

107

1.88

1.86

1.1

1.2

35.53

24.69

u/l

0.21

Other enthesopathies

104

801

1.30

1.85

1.2

1.1

18.85

23.33

u/l

0.47

719

Specific development disorders of speech and language

2.03

1.85

1.2

16.44

23.20

u/l

0.36

Other anxiety disorders

141

958

1.25

1.84

1.1

1.2

32.33

19.28

u/l

0.72

125

867

Squamous cell neoplasms and carcinomas of the skin

190

1.63

1.83

1.2

1.1

29.12

25.24

u/l

0.21

159

Car occupant injured in other and unspecified transport accidents

401

1.42

1.81

1.1

20.73

20.62

u/l

0.01

363

Open wound of wrist and hand

137

1059

1.25

1.80

1.2

26.01

25.62

u/l

0.02

122

952

Hernia

331

1901

1.16

1.80

1.1

27.28

23.50

u/l

0.51

298

1691

Dislocation of lens

3.07

1.80

1.4

1.2

18.57

20.94

u/l

—

Use of pramipexole

597

1.34

1.79

1.1

18.62

26.80

u/l

1.31

527

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

395

1.42

1.76

1.2

24.87

16.13

u/l

0.44

364

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

199

1.60

1.76

1.1

1.2

22.28

19.08

u/l

0.18

181

Personal history of risk-factors, not elsewhere classified

3.36

1.75

1.7

1.2

10.83

40.38

u/l

—

Ulcer of oesophagus

117

1.80

1.74

1.2

18.00

32.02

u/l

1.50

106

Injuries to the neck

523

1.36

1.74

1.1

16.65

22.40

u/l

0.97

472

Strabismus

625

1.33

1.73

1.1

1.2

21.94

22.79

u/l

0.06

561

Other factor of the environment

2.94

1.73

1.0

1.1

18.57

22.33

u/l

—

Other condition

314

1.47

1.72

1.3

1.1

46.75

21.66

u/l

0.74

281

Contact with other and unspecified heat and hot substances

3.90

1.72

1.0

1.2

78.40

27.44

u/l

—

Acute drug-induced interstitial lung disorder

3.89

1.72

1.2

1.3

36.40

42.85

u/l

—

Bacterial pneumoniae

128

897

1.25

1.71

1.2

1.1

20.88

22.97

u/l

0.28

114

783

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

343

1.36

1.70

1.1

1.2

16.93

14.41

u/l

0.25

323

Use of other anti-dementia drugs

618

0.71

1.70

1.1

28.36

29.26

u/l

0.05

528

Use of memantine

618

0.71

1.70

1.1

28.36

29.26

u/l

0.05

528

Other secondary gonarthrosis

118

1.79

1.70

1.3

1.2

19.14

19.84

u/l

0.04

106

Intracerebral haemorrhage

266

1.51

1.70

1.3

1.1

40.38

22.42

u/l

0.54

236

Retinal detachments and breaks

122

974

1.25

1.67

1.2

1.1

20.47

23.39

u/l

0.29

108

856

Hallux valgus (acquired)

120

680

1.26

1.67

1.1

14.69

23.76

u/l

3.37

101

606

Atopic dermatitis

187

1239

1.20

1.67

1.2

1.1

15.80

22.27

u/l

1.67

175

1106

COPD related to multimorbidity

134

914

1.24

1.64

1.2

1.1

22.00

27.98

u/l

1.16

118

795

Chronic sinusitis

143

1164

1.23

1.63

1.1

18.77

24.04

u/l

1.04

128

1045

Pregnancy hypertension

142

1032

1.23

1.63

1.1

1.2

19.23

17.54

u/l

0.22

130

933

Lymphangioma, anys site

3.61

1.62

1.0

1.2

15.40

26.05

u/l

—

Certain conditions originating in the perinatal period

106

1.76

1.61

1.1

1.2

15.21

17.41

u/l

0.16

Spirochaetal infections, other/unspecified

222

1.54

1.59

1.3

1.2

14.50

25.82

u/l

2.07

199

Superficial injury of lower leg

671

1.30

1.59

1.1

1.2

28.58

23.87

u/l

0.22

596

Female genital prolapse

109

476

1.27

1.58

1.1

17.04

22.17

u/l

0.89

432

Injury of nerves at forearm level

3.02

1.58

1.2

1.1

6.50

30.54

u/l

—

Primary open-angle glaucoma, strict

740

1.28

1.58

1.2

1.1

17.23

26.64

u/l

2.73

649

Combinations of oral blood glucose lowering drugs

698

1.29

1.58

1.1

1.2

26.15

25.87

u/l

0.02

616

Neuromuscular dysfunction of bladder

199

1.56

1.2

1.1

30.64

25.59

u/l

0.21

179

Excessive vomiting in pregnancy

152

1.65

1.56

1.1

12.18

17.10

u/l

0.85

137

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

440

1.37

1.54

1.3

1.2

20.33

17.67

u/l

0.33

403

Sequelae of injuries, of poisoning and of other consequences of external causes

552

1.32

1.54

1.1

26.07

22.26

u/l

0.21

496

Pneumococcal septicemia

2.04

1.54

1.1

1.2

21.00

26.81

u/l

0.33

Complications of other internal prosthetic devices, implants and grafts

1.93

1.54

1.2

1.1

23.07

24.12

u/l

0.03

Trochanteric bursitis

381

1.39

1.54

1.2

1.1

16.55

21.49

u/l

0.50

336

Emotionally unstable personality disorder

216

1.53

1.3

1.1

10.65

17.14

u/l

1.89

202

Lumbar disc prolapse

219

1381

1.17

1.53

1.2

1.1

20.79

24.32

u/l

0.61

200

1231

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

159

1144

1.21

1.51

1.1

1.2

18.33

18.75

u/l

0.05

146

1033

Disorders of refraction and accommodation

683

1.28

1.50

1.3

1.2

18.22

20.79

u/l

0.25

614

Schizophrenia, schizotypal and delusional disorders

713

1.28

1.49

1.2

16.53

22.16

u/l

1.15

645

Nonischemic cardiomyopathy

202

1.54

1.47

1.0

1.1

22.76

27.93

u/l

0.39

176

Nontraumatic intracranial haemmorrhage

497

1.33

1.45

1.2

1.1

36.61

25.29

u/l

0.54

437

Umbilical hernia

628

1.29

1.45

1.2

1.1

34.69

28.12

u/l

0.28

554

Other or ill-defined heart diseases

102

1.77

1.44

1.3

1.1

36.30

21.57

u/l

0.81

Traction detachment of retina

3.16

1.44

1.0

1.3

14.40

32.11

u/l

—

Lifestyle-related condition

2.75

1.44

1.0

1.1

19.17

31.17

u/l

—

Alcohol abuse, main dg

303

1.42

1.41

1.1

27.69

26.03

u/l

0.08

277

Conjunctivitis (acute, non atopic)

689

1.27

1.41

1.3

1.1

19.18

23.33

u/l

0.57

610

Fracture of shoulder and upper arm

121

987

1.23

1.40

1.2

1.1

28.61

24.88

u/l

0.22

105

871

Myocardial infarction, with ST-elevation

380

1.37

1.39

1.1

24.48

30.77

u/l

0.54

330

Allergic asthma (mode), excluding more controls

429

1.34

1.39

1.1

26.85

17.47

u/l

0.51

379

Other disorders of eyelid

165

1310

1.19

1.39

1.1

18.63

26.32

u/l

2.31

148

1149

Atopic dermatitis, strict definition

635

1.28

1.39

1.2

19.05

17.41

u/l

0.13

575

Schizophrenia or delusion

712

1.27

1.39

1.2

16.57

22.20

u/l

1.13

643

Other and unspecified diseases of blood and blood-forming organs

2.09

1.39

1.0

1.2

61.62

29.20

u/l

0.36

Hydrocele

222

1.49

1.38

1.1

19.65

35.53

u/l

1.38

196

Stomatitis and related lesions

476

1.33

1.37

1.1

19.73

23.53

u/l

0.43

422

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

2.62

1.37

1.0

1.3

40.50

38.62

u/l

—

COPD, early/later onset

152

1068

1.20

1.35

1.2

1.1

21.66

27.37

u/l

1.12

131

930

Meniscus derangement

178

1000

1.18

1.35

1.1

23.15

23.94

u/l

0.09

151

894

Lesion of radial nerve

1.87

1.34

1.1

1.2

29.21

26.79

u/l

0.07

Event of undetermined intent

120

1.67

1.34

1.1

1.2

14.72

22.21

u/l

0.82

114

Allergic rhinitis

698

1.26

1.33

1.1

1.2

13.26

18.36

u/l

1.47

631

Nonorganic sleeping disorders

496

1.31

1.33

1.2

26.87

21.41

u/l

0.25

447

Behavioural syndromes associated with physiological disturbances and physical factors

325

1951

1.13

1.30

1.2

1.1

22.51

23.29

u/l

0.09

293

1743

Adhesive capsulitis of shoulder

420

1.34

1.30

1.3

1.1

12.45

24.45

u/l

3.20

379

Other female pelvic inflammatory diseases

429

1.33

1.29

1.2

20.66

19.66

u/l

0.05

388

Villonodular synovitis (pigmented)

2.80

1.29

1.2

1.1

29.00

35.56

u/l

—

Fracture of skull and facial bones

473

1.31

1.28

1.2

1.1

33.00

22.39

u/l

0.55

428

Other and unspecified tonsillitis

501

1.28

1.2

19.18

24.14

u/l

0.49

456

Haemolytic anaemias

1.94

1.28

1.7

1.1

30.08

25.92

u/l

0.12

COPD, hospital admissions

150

1064

1.19

1.27

1.2

1.1

21.78

27.44

u/l

1.09

130

925

Chronic rhinitis, nasopharyngitis and pharyngitis

105

856

1.23

1.27

1.2

1.1

17.74

24.94

u/l

1.33

768

Noninflammatory disorders of female genital tract

128

529

1.22

1.26

1.1

18.86

20.76

u/l

0.24

114

481

Any dementia

820

0.81

1.26

1.1

27.00

27.22

u/l

0.02

699

Later onset COPD, excluding more controls

373

1.31

1.26

1.2

1.1

21.50

24.79

u/l

0.33

310

Non-allergic asthma (mode), excluding more controls

367

1.35

1.26

1.1

27.27

20.49

u/l

0.32

317

Bacterial pneumonia (organism specified)

144

1096

1.19

1.25

1.2

1.1

23.07

24.40

u/l

0.17

130

955

Varicose veins

226

1485

1.15

1.25

1.1

21.66

23.97

u/l

0.34

196

1323

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

181

1487

1.17

1.25

1.1

21.12

21.77

u/l

0.06

171

1325

Nonsuppurative otitis media, including avohilmo

585

1.26

1.25

1.2

35.36

19.18

u/l

0.86

525

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

112

911

1.21

1.22

1.1

1.2

16.70

20.12

u/l

0.52

101

830

Obstructed labour due to malposition and malpresentation of fetus

482

1.29

1.21

1.2

13.93

17.37

u/l

0.66

449

Adenocarcinoma and papilloma adenocarcinoma of rectum

196

1.48

1.21

1.1

27.79

22.42

u/l

0.31

165

Disorders of speech understanding and production

1.97

1.21

1.2

1.1

21.91

24.66

u/l

0.09

Haemorrhage in early pregnancy

742

0.77

1.20

1.1

1.2

17.74

18.13

u/l

0.02

684

Nontoxic multinodular goitre

523

1.28

1.19

1.1

15.71

23.71

u/l

2.18

464

Other acute viral hepatitis

2.32

1.19

1.2

13.17

35.72

u/l

—

Pterygium

1.88

1.18

1.2

15.58

28.43

u/l

0.86

Sleep disorders

312

1918

1.12

1.16

1.2

1.1

22.46

23.50

u/l

0.12

280

1715

Disorders of tooth development and eruption

256

1.37

1.15

1.2

1.1

12.89

23.12

u/l

2.03

236

Aortic aneurysm

515

1.28

1.15

1.1

25.14

24.48

u/l

0.05

445

Phakomatoses, not elsewhere classified

2.52

1.15

1.4

1.2

51.38

28.29

u/l

—

Endometriosis of intestine

2.51

1.15

1.0

1.1

100.60

14.40

u/l

—

Allergic asthma (mode)

444

1.30

1.15

1.1

26.85

20.83

u/l

0.28

392

Radial styloid tenosynovitis [de Quervain]

118

1.61

1.14

1.1

1.2

25.52

21.17

u/l

0.19

109

Diseases of male genital organs

124

519

1.20

1.14

1.1

1.2

29.09

30.68

u/l

0.09

113

463

Leiomyoma of uterus

234

1151

1.14

1.1

20.96

20.18

u/l

0.09

213

1028

Injuries to the shoulder and upper arm

297

2045

1.12

1.14

1.2

1.1

27.14

23.41

u/l

0.43

261

1825

Acetic acid derivatives and related substances

342

1.26

1.14

1.1

1.2

32.35

28.32

u/l

0.15

302

Blepharochalasis

109

906

1.20

1.12

1.1

18.81

24.81

u/l

0.99

805

Sacroiliitis, not elsewhere classified

1.71

1.11

1.3

1.2

16.87

21.15

u/l

0.19

Myopia

259

1.39

1.11

1.4

1.2

25.88

17.23

u/l

0.39

239

Melanocytic naevi

808

1.21

1.10

1.3

1.1

18.38

22.68

u/l

0.67

725

Other strabismus

492

1.28

1.10

1.1

1.2

19.71

22.48

u/l

0.21

441

Toxic effects of substances chiefly nonmedicinal as to source

226

1.42

1.09

1.2

1.1

39.89

21.91

u/l

0.38

202

Palmar fascial fibromatosis [Dupuytren]

337

1.34

1.09

1.2

1.1

20.74

30.32

u/l

1.19

295

Chronic conjunctivitis

1.83

1.09

1.3

1.1

7.24

26.53

u/l

2.94

Spirochaetal infections, other/unspecified, including avohilmo

984

0.81

1.08

1.2

1.1

16.25

23.68

u/l

2.07

877

Tinnitus

603

1.25

1.07

1.2

1.1

23.49

24.29

u/l

0.05

529

Dementia in Alzheimer disease

381

0.72

1.06

1.1

44.71

29.73

u/l

0.53

329

Single spontaneous delivery

626

0.83

1.06

1.1

1.2

17.16

24.62

u/l

1.31

557

Lyme disease, including avohilmo

980

0.82

1.05

1.2

1.1

16.25

23.69

u/l

2.07

873

Lyme disease

980

0.82

1.05

1.2

1.1

16.25

23.69

u/l

2.07

873

Allergic conjunctivitis

188

1582

1.14

1.04

1.1

1.2

20.71

21.37

u/l

0.06

177

1412

Extrapyramidal and movement disorders

131

1117

1.17

1.03

1.1

18.29

24.65

u/l

1.70

109

988

Injury of eye and orbit

280

1.36

1.03

1.1

75.72

23.14

u/l

0.79

257

Malignant neoplasm of stomach, including Hilmo

1.64

1.03

1.1

25.42

27.00

u/l

0.05

Vascular dementia (mixed)

2.07

1.03

1.3

1.1

33.00

49.14

u/l

—

ILD-related respiratory insufficiency

1.84

1.03

1.5

1.2

24.00

32.94

u/l

0.47

Other spirochaetal diseases

987

0.82

1.02

1.2

1.1

16.38

23.69

u/l

2.04

879

Endometriosis ASRM stages 3,4

590

1.24

1.01

1.1

1.2

25.71

19.30

u/l

0.46

527

Medical abortion

221

1056

1.13

1.00

1.1

20.28

20.14

u/l

0.02

199

950

Disorder of the sleep-wake schedule

2.01

1.00

1.4

1.2

5.70

29.71

u/l

—

Herpesviral [herpes simplex] infections, including avohilmo

627

1.23

1.00

1.2

1.1

23.15

21.50

u/l

0.16

567

Other noninflammatory disorders of uterus, except cervix

428

1.23

1.00

1.2

1.1

23.20

22.72

u/l

0.03

386

Other spirochaetal diseases, including avohilmo

995

0.82

0.99

1.2

1.1

16.27

23.55

u/l

2.06

887

Other disorders of veins

148

1259

1.16

0.99

1.1

22.81

23.75

u/l

0.10

129

1129

Use of donepezil

514

0.76

0.98

1.0

1.1

26.55

30.45

u/l

0.15

441

Benign neoplasm: Rectum, anus and anal canal

530

1.25

0.98

1.2

1.1

19.03

27.71

u/l

1.43

469

Other viral diseases, not elsewhere classified, including avohilmo

598

1.23

0.97

1.2

1.1

23.02

20.49

u/l

0.26

541

Tonsillectomy and adenotomy

119

972

0.85

0.97

1.2

18.85

19.66

u/l

0.06

109

883

Sequelae of other external causes

116

1.56

0.96

1.2

1.1

59.83

22.10

u/l

0.68

106

Retinal detachment with retinal break

310

1.32

0.96

1.1

17.36

27.97

u/l

1.34

276

Hallux rigidus

345

1.31

0.96

1.1

17.93

24.45

u/l

0.62

302

Superficial injury of abdomen, lower back and pelvis

328

1.31

0.95

1.1

17.58

22.81

u/l

0.66

294

Malignant neoplasm of corpus uteri

191

1.42

0.94

1.2

1.1

18.50

19.90

u/l

0.10

159

Alcohol dependence

596

1.23

0.94

1.2

1.1

62.25

24.30

u/l

0.99

533

Right hemicolectomy

125

1.52

0.94

1.2

1.1

50.95

28.51

u/l

0.43

110

Polycystic ovarian syndrome

1.72

0.92

1.1

12.24

14.97

u/l

0.27

Complications of labour and delivery

210

1034

1.13

0.92

1.1

1.2

15.56

20.41

u/l

1.53

188

930

Tularaemia

2.16

0.91

1.0

1.2

29.83

31.32

u/l

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

200

1379

1.13

0.90

1.2

1.1

17.99

21.43

u/l

0.74

178

1241

Other fall from one level to another

473

1.25

0.90

1.1

31.14

25.73

u/l

0.23

421

Acne vulgaris

118

1.52

0.90

1.4

1.2

8.33

17.22

u/l

2.07

107

Other benign neoplasms of skin

122

1050

1.16

0.89

1.2

1.1

23.13

23.72

u/l

0.04

112

927

Lichen ruber planus, wide definition including periferal and oral lichen planus

628

1.21

0.88

1.2

1.1

16.40

24.02

u/l

1.77

560

Dermatophytosis, including avohilmo

212

1856

1.12

0.88

1.1

1.2

22.94

22.22

u/l

0.07

184

1664

Childhood asthma (age<16), excluding more controls

118

1.46

0.87

1.1

1.2

14.77

9.08

u/l

0.55

108

Pedal cyclist injured in transport accident

539

0.78

0.87

1.2

1.1

42.54

22.06

u/l

0.54

486

Effects of foreign body entering through natural orifice

521

1.23

0.86

1.3

1.1

26.76

27.91

u/l

0.04

463

Oxicams

324

1.23

0.86

1.1

1.2

37.36

29.60

u/l

0.25

284

Benign neoplasm: Vulva

1.83

0.86

1.0

1.1

9.25

25.16

u/l

—

Carcinoma in situ of skin of lower limb, including hip

1.83

0.86

1.4

1.2

20.25

30.59

u/l

—

Small cell lung cancer, helper endpoint

1.82

0.86

1.0

1.3

46.13

29.27

u/l

—

Small cell lung cancer, including Hilmo

1.82

0.86

1.0

1.2

46.13

23.46

u/l

—

Small cell lung cancer

1.82

0.86

1.0

1.2

46.13

23.46

u/l

—

Lichen planus, including avohilmo

522

1.23

0.85

1.2

1.1

14.72

24.37

u/l

2.32

467

Insomnia

300

1900

1.10

0.85

1.2

1.1

21.62

23.49

u/l

0.23

269

1703

Childhood asthma (age<16)

119

1.45

0.84

1.1

1.2

14.77

9.30

u/l

0.52

109

Unspecified/other endometriosis

167

1.41

0.83

1.1

18.33

15.17

u/l

0.28

156

Achilles tendinitis

266

1.32

0.82

1.2

1.1

18.34

24.89

u/l

0.55

240

Benign neoplasm: Sigmoid colon

498

1.23

0.81

1.3

1.1

24.94

29.13

u/l

0.19

442

Asthma and opportunity respiratory infection

105

1.53

0.81

1.0

1.1

34.00

25.79

u/l

0.35

Malignant neoplasm of stomach

1.58

0.81

1.1

27.76

26.08

u/l

0.05

Use of antiglaucoma preparations and miotics

172

1.40

0.80

1.1

16.19

26.19

u/l

1.24

153

Superficial injury of wrist and hand

463

1.23

0.80

1.1

1.2

17.53

21.57

u/l

0.51

414

Schizophrenia

329

1.28

0.80

1.1

16.03

21.15

u/l

0.53

297

Non-allergic asthma (mode)

397

1.25

0.79

1.1

27.27

23.73

u/l

0.15

339

Glaucoma, exfoliation

259

1.31

0.79

1.3

1.1

12.80

29.58

u/l

3.29

230

Other and unspecified glaucoma

156

1.41

0.78

1.1

15.94

27.00

u/l

1.26

140

Complications associated with artificial fertilization

0.00

0.78

0.0

1.1

—

13.15

—

Delivery

102

626

0.86

0.78

1.1

1.2

15.60

24.62

u/l

1.90

557

Transport accidents

138

1010

1.14

0.77

1.2

1.1

26.55

21.20

u/l

0.39

122

916

Benign neoplasm: Skin of other and unspecified parts of face

243

1.32

0.77

1.2

12.62

25.97

u/l

3.48

217

Bacterial pneumonia, not elsewhere classified

112

853

1.15

0.76

1.1

20.38

21.51

u/l

0.14

100

742

Malignant neoplasm of larynx, including Hilmo

0.00

0.76

0.0

1.2

—

29.09

—

Rosacea

332

1.27

0.75

1.2

1.1

10.13

20.79

u/l

3.47

296

Other disorders of choroid

2.09

0.74

1.0

1.2

15.00

18.15

u/l

—

Soft tissue disorders related to use, overuse and pressure

743

1.17

0.74

1.1

30.22

25.37

u/l

0.23

660

Other and unspecified nonorganic psychotic disorders

378

1.24

0.74

1.2

13.19

19.35

u/l

1.16

342

Impingement syndrome of shoulder

615

1.19

0.73

1.1

29.42

26.04

u/l

0.14

548

Conduct disorder

2.01

0.72

1.0

1.1

10.80

9.36

u/l

—

Voice disturbances

755

1.17

0.72

1.1

16.42

24.74

u/l

1.82

669

Preterm labour and delivery

727

1.17

0.72

1.1

1.2

16.17

18.62

u/l

0.39

662

Multiple delivery

230

0.69

0.72

1.1

1.2

11.22

18.75

u/l

1.28

212

Pleural plaque without asbestos

1.62

0.71

1.4

1.2

43.18

36.21

u/l

0.13

Alzheimer disease, excluding more controls

304

0.79

0.71

1.1

30.66

20.95

u/l

0.83

262

Glaucoma suspect

124

1091

1.14

0.71

1.2

1.1

20.85

24.61

u/l

0.58

104

974

Muscle strain

1.58

0.71

1.2

78.33

22.38

u/l

—

Family history of other conditions

1.93

0.70

1.0

1.1

19.40

32.65

u/l

—

Cardiomyopathy, other and unspecified

143

1.40

0.70

1.0

1.1

21.15

26.13

u/l

0.23

129

Melanocytic naevi of trunk

256

1.29

0.70

1.3

1.1

17.20

23.14

u/l

0.47

232

Diseases of appendix

237

1935

1.09

0.69

1.2

14.51

23.99

u/l

7.58

210

1738

Injury of muscle and tendon at hip and thigh level

221

1.31

0.69

1.1

9.60

22.30

u/l

3.95

202

Acute bronchiolitis

1.53

0.68

1.0

1.2

34.33

13.41

u/l

—

Nasal polyp

442

0.79

0.68

1.1

27.44

28.13

u/l

0.02

396

Delivery, wide proxy

491

0.85

0.68

1.2

19.72

25.62

u/l

0.64

430

Acute alcohol intoxication

565

1.19

0.68

1.1

26.46

24.01

u/l

0.19

509

Malignant neoplasm of other connective and soft tissue

1.63

0.67

1.1

1.2

46.14

24.97

u/l

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

117

778

0.88

0.66

1.1

1.2

15.90

17.12

u/l

0.15

106

711

Pregnancy with abortive outcome

224

1063

1.10

0.66

1.2

1.1

18.73

20.14

u/l

0.23

201

955

Malignant neoplasm of eye, brain and central nervous system

1.57

0.65

1.3

1.1

25.18

21.78

u/l

0.07

Benign lipomatous neoplasm

829

0.86

0.64

1.1

15.03

25.01

u/l

2.25

741

Nontoxic goitre/thyroid nodule

858

1.14

0.63

1.1

15.86

22.02

u/l

2.05

766

Any dementia, excluding more controls

724

0.87

0.63

1.1

26.53

24.77

u/l

0.16

620

Dementia

118

909

0.89

0.62

1.1

24.04

25.99

u/l

0.22

787

Dislocation, sprain and strain of joints and ligaments at neck level

306

1.24

0.62

1.1

17.06

17.69

u/l

0.05

283

HSIL lesion of the cervix uteri, vagina or vulva

471

1.19

0.60

1.2

18.22

15.98

u/l

0.33

439

Ehlers-Danlos syndrome

0.00

0.60

0.0

1.2

—

28.38

—

Intermittent heterotropia

1.48

0.60

1.2

10.45

24.22

u/l

2.42

Fenamates

239

1.23

0.59

1.2

14.27

30.56

u/l

3.61

209

Other lesions of median nerve

1.54

0.59

1.3

1.1

6.13

25.41

u/l

—

Periapical abscess

121

1352

0.89

0.59

1.2

1.1

27.48

24.08

u/l

0.20

108

1212

Focal epilepsy

491

1.18

0.58

1.2

1.1

23.38

25.36

u/l

0.14

437

Spondylolisthesis/Spondylolysis

510

1.18

0.58

1.2

1.1

18.51

22.79

u/l

0.63

452

Malignant neoplasm of brain

1.51

0.58

1.3

1.2

32.13

23.78

u/l

—

Focal epilepsy, strict definition

455

1.19

0.58

1.2

1.1

24.47

25.70

u/l

0.07

402

Hemiplegia

1.46

0.58

1.0

1.2

9.85

24.50

u/l

2.22

Foreign body on external eye

264

1.25

0.58

1.4

1.1

16.62

26.27

u/l

1.40

241

Maternal care for other known or suspected fetal problems

284

1.19

0.57

1.2

12.53

14.56

u/l

0.35

267

Salpingitis and oophoritis

539

1.17

0.57

1.0

1.2

26.11

19.94

u/l

0.35

493

Alzheimer’s disease (Early onset)

0.57

0.56

1.0

1.2

30.80

25.86

u/l

—

Ulcer of vagina/vulva

1.46

0.56

1.4

1.2

13.62

20.40

u/l

—

malignant neoplasm of female genital organs, including Hilmo

409

1.19

0.56

1.2

1.1

22.89

17.89

u/l

0.49

349

Pneumothorax

133

1.36

0.55

1.1

1.2

45.03

29.87

u/l

0.26

117

Ectopic pregnancy

493

0.83

0.54

1.1

1.2

24.08

18.58

u/l

0.30

454

Subjective visual disturbances

673

1.14

0.54

1.2

1.1

14.42

24.36

u/l

2.99

603

Female infertility

451

0.86

0.53

1.2

1.1

18.77

19.20

u/l

0.03

415

Lateral epicondylitis

322

1.21

0.53

1.1

23.14

20.48

u/l

0.10

295

Oter anti-inflammatory and antirheumatic agents, non-steroids

307

1.16

0.52

1.1

31.71

30.57

u/l

0.04

269

Injuries to unspecified part of trunk, limb or body region

205

1.27

0.52

1.2

24.85

23.07

u/l

0.08

185

Malignant neoplasm of other connective and soft tissue, including Hilmo

1.43

0.52

1.1

41.56

30.45

u/l

—

Coxibs

347

1.15

0.52

1.1

1.2

30.40

27.92

u/l

0.08

307

Localized swelling, mass and lump of skin and subcutaneous tissue

865

1.12

0.51

1.1

25.81

23.46

u/l

0.23

767

Malignant neoplasm of mesothelium and soft tissue

1.39

0.50

1.1

60.11

28.92

u/l

—

Cyst of kidney

144

1.32

0.50

1.1

16.20

30.29

u/l

1.48

127

Gestational [pregnancy-induced] hypertension

601

1.15

0.50

1.1

1.2

17.57

17.38

u/l

0.02

544

Tularaemia, including avohilmo

1.47

0.50

1.0

1.1

29.83

31.47

u/l

—

Propionic acid derivatives

353

1.14

0.50

1.2

24.73

27.54

u/l

0.20

312

All dysplastic lesions of the cervix uteri

626

0.86

0.48

1.1

1.2

17.57

16.03

u/l

0.13

579

Malignant neoplasm of brain, including Hilmo

1.45

0.48

1.3

1.1

30.73

21.06

u/l

0.21

Abnormal findings in secretions and smears from cervix uteri vagina vulva

138

1111

0.91

0.47

1.2

16.93

17.65

u/l

0.10

127

1005

COPD, hospital admission 2, with asthma infections

732

1.12

0.47

1.2

1.1

25.08

28.79

u/l

0.41

632

Endometriosis

515

1.12

0.47

1.1

25.34

20.95

u/l

0.36

469

Conjunctivitis (acute, non atopic), including avohilmo

331

1884

1.06

0.47

1.2

1.1

18.07

24.63

u/l

2.12

290

1673

Focal epilepsy, mode (most common among epilepsy diagnosis)

429

1.17

0.46

1.2

1.1

23.40

26.30

u/l

0.19

382

Ocular pain

191

1.26

0.46

1.3

1.2

14.32

20.17

u/l

0.84

175

Injury of muscle and tendon at lower leg level

328

1.19

0.46

1.2

1.1

29.46

25.45

u/l

0.21

296

Antepartum haemorrhage, not elsewhere classified

153

0.72

0.45

1.0

1.2

11.82

16.29

u/l

0.54

145

Carcinoma in situ of skin of scalp and neck

1.37

0.44

1.0

1.2

32.00

39.12

u/l

—

Caught, crushed, jammed or pinched in or between objects

1.37

0.43

1.2

70.68

24.05

u/l

0.43

Ingrowing nail

104

1.35

0.43

1.0

1.2

65.86

23.66

u/l

0.41

1.41

0.42

1.1

19.73

33.85

u/l

1.03

Struck by thrown, projected or falling objec

0.64

0.42

1.0

1.2

14.67

25.71

u/l

—

Benign mammary dysplasia

381

0.84

0.41

1.1

12.13

21.54

u/l

3.32

338

Hypermetropia

140

1.29

0.41

1.1

1.2

17.61

20.62

u/l

0.23

127

Right side

0.00

0.41

0.0

1.3

—

38.11

—

Coarctation of the aorta

0.00

0.41

0.0

1.2

—

28.18

—

Other and unspecified pemphigoid

0.00

0.41

0.0

1.3

—

42.06

—

Appendicitis, broad definition

229

1929

1.06

0.41

1.2

14.39

24.01

u/l

7.62

202

1732

Unspecified maternal hypertension

0.00

0.40

0.0

1.2

—

30.83

—

Crossbite

113

1.30

0.40

1.2

11.00

17.86

u/l

0.93

105

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

123

1.30

0.40

1.3

1.2

22.27

22.09

u/l

0.00

110

Melanocytic naevi of eyelid, including canthus

0.00

0.40

0.0

1.3

—

25.06

—

Chronic diseases of tonsils and adenoids

238

1411

1.06

0.40

1.2

16.63

24.23

u/l

2.56

217

1276

Organic, including symptomatic, mental disorders

165

1078

1.08

0.40

1.1

23.96

25.51

u/l

0.20

139

943

Injury of nerves at ankle and foot level

0.00

0.39

0.0

1.1

—

36.11

—

Frostbite

0.00

0.39

0.0

1.2

—

35.72

—

Dementia, including avohilmo

130

961

0.92

0.39

1.1

24.19

25.66

u/l

0.17

108

831

COPD, hospital admissions 3, with asthma pneumonia sepsis

585

1.11

0.38

1.2

1.1

21.63

31.81

u/l

1.59

506

Examination and encounter for administrative purposes

160

1.25

0.38

1.3

1.1

25.50

25.59

u/l

0.00

134

Other orthopaedic follow-up care

115

0.69

0.37

1.6

1.1

28.50

17.53

u/l

—

104

Hydrocephalus

152

1.25

0.37

1.2

19.64

25.55

u/l

0.23

132

Panniculitis affecting regions of neck and back

0.64

0.35

1.2

29.20

25.93

u/l

—

Adenocarcinoma and papillary adenocarcinoma of stomach

1.40

0.35

1.3

1.2

44.33

25.62

u/l

—

Cervicalgia

556

1.12

0.34

1.2

1.1

25.94

23.69

u/l

0.12

494

Acute appendicitis, no complications

163

1518

1.07

0.34

1.2

15.90

24.02

u/l

3.98

144

1368

Diabetes mellitus in pregnancy

461

1.10

0.34

1.2

16.70

14.55

u/l

0.29

435

Other acquired deformities of musculoskeletal system and connective tissue

1.32

0.33

1.1

1.2

44.51

25.08

u/l

0.59

Urethral stricture

100

1.30

0.33

1.0

1.1

25.14

40.47

u/l

—

Embedded teeth, including avohilmo

136

1.25

0.33

1.1

1.2

14.76

19.36

u/l

0.31

130

Chronic mastoiditis

1.31

0.33

1.5

1.1

103.17

30.53

u/l

—

Emotional disorders and disorders of social functioning with onset specific to childhood

1.28

0.32

1.0

1.2

8.50

13.32

u/l

—

Persons encountering health services in circumstances related to reproduction

173

1091

1.06

0.31

1.1

1.2

17.67

23.44

u/l

1.39

155

992

Other complications of labour and delivery, not elsewhere classified

146

0.79

0.31

1.2

1.3

11.31

16.30

u/l

0.67

139

Inguinal hernia

137

973

0.94

0.31

1.1

1.2

32.82

26.97

u/l

0.43

121

852

Epiphora

1.35

0.31

1.0

1.2

20.00

33.38

u/l

—

Benign neoplasm: other/unspecified salivary gland

1.27

0.30

1.0

1.2

46.49

26.16

u/l

—

Appendectomy

196

1771

1.05

0.29

1.2

1.1

16.24

23.37

u/l

2.08

174

1592

Brain meningioma

110

0.73

0.28

1.1

37.75

17.66

u/l

—

malignant neoplasm of female genital organs

365

1.13

0.28

1.2

1.1

21.95

18.57

u/l

0.28

307

Sequelae of injuries of upper limb

223

1.17

0.28

1.0

1.2

17.48

20.50

u/l

0.33

205

Prolapse and hernia of ovary and fallopian tube

1.30

0.28

1.1

21.50

30.28

u/l

—

Redundant prepuce, phimosis and paraphimosis

368

1.12

0.28

1.1

1.2

28.62

34.84

u/l

0.32

330

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

720

1.08

0.27

1.3

1.1

32.68

25.94

u/l

0.31

639

Acute appendicitis

211

1867

1.05

0.27

1.2

14.95

23.95

u/l

6.29

186

1676

Maternal care for known or suspected abnormality of pelvic organs

388

0.90

0.27

1.2

10.96

15.98

u/l

1.50

363

COPD, hospital admissions 1, only main diagnosis

784

1.07

0.27

1.2

1.1

22.75

28.58

u/l

0.82

677

Adverse effects, not elsewhere classified

461

1.11

0.27

1.1

1.2

24.22

18.76

u/l

0.36

415

Triptan medication for migraine, min. 3 purchases

156

1230

0.95

0.26

1.2

17.62

18.71

u/l

0.14

145

1119

Use of ropinirole

0.70

0.26

1.0

1.2

34.40

24.74

u/l

—

171

0.82

0.26

1.1

30.89

34.45

u/l

—

154

Alzheimer’s disease (Early onset), excluding more controls

0.67

0.26

1.0

1.1

30.80

23.33

u/l

—

Malignant neoplasm of rectum

197

1.17

0.25

1.0

1.1

30.43

26.27

u/l

0.17

166

Anti-inflammatory and antirheumatic products, non-steroids

353

1.08

0.24

1.1

1.2

25.51

27.54

u/l

0.13

312

Other abnormal products of conception

550

1.07

0.24

1.1

1.2

18.62

15.96

u/l

0.30

515

Radiculopathy

407

1.11

0.24

1.2

1.1

21.25

26.29

u/l

0.35

363

Contraceptive management

120

790

1.06

0.24

1.2

14.77

21.15

u/l

1.60

109

723

Mouth breathing

109

1024

1.06

0.24

1.2

1.1

15.38

26.49

u/l

4.00

919

Other degenerative diseases of the nervous system

536

0.92

0.23

1.1

24.28

20.84

u/l

0.40

480

Malignant neoplasm of cervix uteri, including Hilmo

1.28

0.23

1.0

1.2

39.80

14.41

u/l

—

Other maternal disorders predominantly related to pregnancy

169

1106

0.96

0.22

1.2

16.74

19.44

u/l

0.41

144

1010

Carcinoma in situ of breast

0.00

0.21

0.0

1.3

—

17.19

—

Carcinoma in situ of endometrium

0.00

0.21

0.0

1.2

—

20.41

—

Diving or jumping into water causing injury other than drowning or submersion

0.00

0.21

0.0

1.2

—

23.77

—

Thiamine deficiency

0.00

0.21

0.0

1.2

—

27.40

—

Rhinophyma

0.00

0.21

0.0

1.1

—

64.00

—

Ovarian dysfunction, other/unspecified

0.00

0.21

0.0

1.3

—

28.10

—

Motor- or nonmotor-vehicle accident in traffic area

0.00

0.21

0.0

1.2

—

29.97

—

Unspecified parasitic disease

0.00

0.21

0.0

1.3

—

37.55

—

Effects of heat and light

0.00

0.21

0.0

1.2

—

35.77

—

Arnold-Chiari syndrome

0.00

0.21

0.0

1.2

—

27.18

—

Other congenital malformations of nervous system

0.00

0.21

0.0

1.2

—

27.18

—

Pregnancy, childbirth and the puerperium

420

0.93

0.21

1.1

1.2

25.60

23.97

u/l

0.11

364

Implicit parasitic Sepsis, including avohilmo

0.00

0.21

0.0

1.2

—

28.97

—

Superficial frostbite

0.00

0.21

0.0

1.2

—

27.73

—

Endometriosis of fallopian tube

0.00

0.21

0.0

1.2

—

17.25

—

Other and unspecified spinal muscular atrophies

0.00

0.21

0.0

1.2

—

43.83

—

Pediculosis and phthiriasis, including avohilmo

0.00

0.21

0.0

1.2

—

15.21

—

Unspecified parasitic disease, including avohilmo

0.00

0.21

0.0

1.2

—

32.38

—

Other bursitis of elbow

0.00

0.21

0.0

1.5

—

40.68

—

Unequal limb length (acquired)

0.00

0.21

0.0

1.0

—

30.47

—

Benign neoplasm of major salivary glands

230

1.13

0.20

1.3

1.1

26.31

25.84

u/l

0.02

206

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

117

1.20

0.20

1.1

44.48

24.34

u/l

0.60

Other mosquito-borne viral fevers, including avohilmo

0.00

0.20

0.0

1.1

—

12.76

—

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

0.00

0.20

0.0

1.2

—

42.62

—

Gender identity disorders

0.00

0.20

0.0

1.0

—

22.71

—

Disorders of acoustic nerve

1.25

0.20

2.2

1.1

60.92

21.25

u/l

—

Multiple gestation

187

0.86

0.20

1.1

1.2

11.79

15.60

u/l

0.52

177

Benign neoplasm of mouth and pharynx

259

1.12

0.20

1.1

1.2

27.99

23.45

u/l

0.24

232

Renal cell carcinoma of kidney

1.18

0.19

1.2

1.1

13.17

25.09

u/l

—

Benign neoplasm of ovary

510

1.08

0.19

1.2

1.1

21.58

19.67

u/l

0.13

449

Superficial injury of head

597

1.07

0.19

1.1

30.88

23.11

u/l

0.26

534

Medial epicondylitis

1.24

0.18

1.4

1.2

24.99

21.88

u/l

—

Abrasion of teeth

113

1076

1.05

0.18

1.2

1.1

18.43

22.82

u/l

0.81

106

961

Gestational diabetes (for exclusion)

591

0.94

0.18

1.1

1.2

11.81

15.25

u/l

1.09

550

Later onset COPD

615

0.94

0.18

1.2

1.1

20.57

29.50

u/l

1.52

526

Maternal care for other conditions predominantly related to pregnancy

471

1.08

0.17

1.1

1.2

16.22

15.94

u/l

0.02

443

Sacrococcygeal disorders, not elsewhere classified

0.72

0.17

1.8

1.2

27.60

21.94

u/l

—

Vertical strabismus

1.18

0.16

1.0

1.2

44.14

28.52

u/l

—

Abnormal involuntary movements

311

1.09

0.16

1.1

22.03

24.81

u/l

0.23

279

Benign neoplasm of other and unspecified sites

1.14

0.16

1.4

1.2

147.30

25.27

u/l

—

Other epidermal thickening

1.20

0.16

1.3

1.2

19.27

22.61

u/l

0.18

Gonococcal infection, including avohilmo

0.76

0.15

1.0

1.1

15.17

19.99

u/l

—

Endometriosis diagnosis and infertility diagnosis occurring together

224

0.89

0.15

1.1

10.70

15.89

u/l

1.37

209

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

0.81

0.14

1.9

1.2

53.71

25.95

u/l

—

Non-small cell lung cancer, squamous, helper endpoint

0.78

0.14

1.3

1.2

16.43

30.23

u/l

—

Thiazolidinediones

256

1.09

0.14

1.0

1.2

37.82

23.97

u/l

0.75

230

Retinal breaks without detachment

429

0.93

0.14

1.1

1.2

25.96

23.22

u/l

0.09

378

Additional codes for the location of defect, injury or illness

128

0.86

0.13

1.0

1.2

65.40

22.36

u/l

0.36

114

Other menopausal disorders

456

0.95

0.13

1.2

1.1

18.14

20.98

u/l

0.19

415

Injury of other and unspecified intrathoracic organs

117

0.85

0.13

1.3

1.2

24.06

29.33

u/l

—

103

Brain meningioma, including Hilmo

110

0.82

0.13

1.1

151.00

17.66

u/l

—

Chronic suppurative otitis media, including avohilmo

148

0.88

0.12

1.1

1.2

71.31

21.87

u/l

0.46

131

Chronic suppurative otitis media

127

0.87

0.12

1.1

82.82

21.56

u/l

0.48

112

Twin gestation

179

0.89

0.12

1.1

1.2

11.79

15.96

u/l

0.58

169

Childhood allergy (age < 16)

133

1.12

0.12

1.4

1.2

12.28

9.45

u/l

0.25

120

False labour

429

0.95

0.11

1.1

1.2

11.66

15.32

u/l

0.53

397

Dysplasia of cervi uteri

435

0.95

0.11

1.1

19.00

17.48

u/l

0.13

400

Burns and corrosions

270

1.07

0.10

1.1

25.87

25.28

u/l

0.03

243

Cervical disc disorders

1013

0.97

0.10

1.1

17.67

24.08

u/l

1.62

903

Other diseases of gallbladder

1.15

0.09

1.2

21.00

22.79

u/l

—

Other and unspecified acute skin changes due to ultraviolet radiation

1.04

0.09

1.4

1.1

11.40

23.02

u/l

—

Motorcycle rider injured in other and unspecified transport accidents

1.13

0.09

1.4

1.2

9.64

20.63

u/l

1.38

Foreign body in respiratory tract

1.13

0.09

1.1

1.2

7.95

24.70

u/l

3.87

Noise effects on inner ear

0.82

0.08

1.0

1.2

7.94

26.70

u/l

—

Adenocarcinoma and ductal carcinoma of pancreas

0.79

0.08

1.0

1.1

87.00

28.54

u/l

—

Respiratory tuberculosis, not confirmed

0.79

0.08

1.0

1.1

18.40

27.54

u/l

—

Respiratory tuberculosis, not confirmed, including avohilmo

0.79

0.08

1.0

1.1

18.40

27.54

u/l

—

Vascular dementia (subcortical)

1.04

0.08

1.1

19.29

39.53

u/l

—

Macular cyst

1.03

0.08

1.4

1.1

8.80

21.19

u/l

—

Gonococcal infection

0.82

0.07

1.0

1.1

15.17

18.28

u/l

—

Benign neoplasm: Parotid gland

186

1.08

0.07

1.3

1.2

17.35

24.25

u/l

0.73

167

Vascular dementia

208

1.07

0.07

1.1

30.94

32.73

u/l

0.08

186

Congenital malformations of eye, ear, face and neck

101

0.89

0.06

1.3

1.2

15.89

22.04

u/l

—

Benign neoplasm: salivary glands, exclude unknown (D119)

207

1.06

0.06

1.3

1.1

25.01

26.33

u/l

0.06

185

Premature rupture of membranes

309

1.04

0.05

1.2

16.93

15.61

u/l

0.11

292

Glucosamine medication

152

1194

1.02

0.05

1.1

30.06

26.01

u/l

0.40

132

1045

Benign neoplasm of other and unspecified female genital organs

109

0.92

0.04

1.0

1.1

9.90

20.34

u/l

—

Cervicobrachial syndrome

607

1.02

0.03

1.1

14.58

22.73

u/l

1.65

543

Caries of enamel

301

1954

1.01

0.03

1.2

1.1

17.66

23.63

u/l

1.60

268

1752

Spontaneous abortion

135

912

0.99

0.02

1.1

1.2

19.77

19.43

u/l

0.04

122

829

Obstructed labour due to maternal pelvic abnormality

449

0.98

0.02

1.2

15.42

19.94

u/l

0.43

405

Other and unspecified effects of external causes

641

1.01

0.01

1.1

1.2

37.78

20.70

u/l

0.65

580

Labour and delivery complicated by fetal stress [distress]

281

1.02

0.01

1.3

1.2

14.08

14.85

u/l

0.08

265

Dislocation, sprain and strain of joints and ligaments of knee

170

1543

1.00

0.01

1.1

1.2

17.69

21.94

u/l

1.05

160

1386

All dysplastic lesions of the cervix uteri, vagina or vulva

727

0.99

0.00

1.1

1.2

21.14

16.11

u/l

0.64

665

Other inflammation of eyelid, including avohilmo

126

1255

1.00

0.00

1.2

1.1

14.07

22.71

u/l

3.32

109

1131

Vascular syndromes of brain in cerebrovascular disorders

101

0.99

0.00

1.2

1.1

17.00

31.30

u/l

—

Acute appendicitis, with complications

476

1.01

0.00

1.1

11.71

25.72

u/l

4.51

429

Other vitreous opacities

1.04

0.00

1.0

1.1

11.80

23.25

u/l

—

Injury of muscle and tendon at shoulder and upper arm level

977

1.00

0.00

1.1

21.54

25.99

u/l

0.42

866

HSIL lesion of the cervix uteri

399

1.00

0.00

1.2

15.11

15.38

u/l

0.03

373

Other and unspecified iridocyclitis

108

1.02

0.00

1.2

18.27

23.43

u/l

0.31

Crushed, pushed or stepped on by crowd or human stampede

127

1.02

0.00

1.1

20.55

20.60

u/l

0.00

115

Unspecified multiple injuries

0.00

0.0

1.0

—

22.14

—

Benign neoplasm: Eye, unspecified

0.00

0.0

1.3

—

20.96

—

Injury of nerves and spinal cord at thorax level

0.00

0.0

1.2

—

8.78

—

Carcinoma in situ of skin of lip

0.00

0.0

1.2

—

51.40

—

Tetralogy of Fallot, a congenital heart defect.

0.00

0.0

1.3

—

12.67

—

Hypospadias

0.00

0.0

1.0

—

2.74

—

Congenital aortic valve stenosis

0.00

0.0

1.0

—

4.94

—

Congenital nasolacrimal duct obstruction or stenosis

0.00

0.0

1.2

—

20.83

—

Assault by hanging, strangulation and suffocation

0.00

0.0

1.0

—

40.67

—

Other congenital malformations of integument, including avohilmo

0.00

0.0

1.2

—

45.54

—

Chromophobe cell carcinoma of kidney

0.00

0.0

1.1

—

33.96

—

Congenital malformations of oesophagus, including avohilmo

0.00

0.0

1.3

—

68.63

—

Femoral hernia, bilateral

0.00

0.0

1.4

—

42.25

—

Occupant of pick-up truck or van injured in other and unspecified transport accidents

0.00

0.0

1.0

—

37.19

—

Enterobiasis

0.00

0.0

1.2

—

25.20

—

Congenital hydrocephalus

0.00

0.0

1.1

—

23.10

—

Acne varioliformis

0.00

0.0

1.0

—

23.54

—

Asymptomatic human immunodeficiency virus [HIV] infection status

0.00

0.0

1.3

—

8.96

—

Other fibroblastic disorders

0.00

0.0

1.2

—

33.50

—

Lesion of medial popliteal nerve

0.00

0.0

1.2

—

26.78

—

Abnormal findings in peritoneal fluid saliva

0.00

0.0

1.3

—

43.52

—

Discontinuity and dislocation of ear ossicles

0.00

0.0

1.1

—

40.25

—

Female infertility, uterine origin

0.00

0.0

1.1

—

11.50

—

Other parasitologically confirmed or unspecified malaria

0.00

0.0

1.2

—

6.12

—

Other and unspecified syphilis

0.00

0.0

1.2

—

8.14

—

Malignant neoplasm of oropharynx, including Hilmo

0.00

0.0

1.3

—

74.33

—

Other and unspecified parapsoriasis

0.00

0.0

1.4

—

19.38

—

Transient retinal artery occlusion

0.00

0.0

1.4

—

13.20

—

Frontotemporal dementia

0.00

0.0

1.3

—

59.50

—

Implicit parasitic Sepsis

0.00

0.0

1.1

—

41.09

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases, including avohilmo

0.00

0.0

1.3

—

6.45

—

Benign neoplasm: Carotid body

0.00

-0.00

0.0

1.1

—

13.81

—

Congenital malformations of posterior segment of eye

0.00

-0.00

0.0

1.0

—

26.14

—

Benign neoplasm: Endocrine gland, other/unspecified

0.00

-0.00

0.0

1.2

—

24.67

—

Benign neoplasm: Female genital organ, unspecified

0.00

-0.00

0.0

1.3

—

24.33

—

Congenital varicose veins

0.00

-0.00

0.0

1.3

—

10.13

—

Multiple system atrophy (rare forms of Parkinsonism)

0.00

-0.00

0.0

1.4

—

26.20

—

Explosion of other materials

0.00

-0.00

0.0

1.2

—

20.20

—

Contact urticaria

0.00

-0.00

0.0

1.4

—

9.60

—

Changes in corneal membranes

0.00

-0.00

0.0

1.3

—

21.40

—

Marfan's syndrome

0.00

-0.00

0.0

1.3

—

9.67

—

Thrombotic microangiopathy

0.00

-0.00

0.0

1.7

—

9.95

—

Cicatricial pemphigoid

0.00

-0.00

0.0

1.2

—

29.60

—

Juvenile cataract

0.00

-0.00

0.0

1.4

—

18.40

—

Melanoma in situ, other sites/unspecified

0.00

-0.00

0.0

1.2

—

61.40

—

Abnormalities of ear ossicles

0.00

-0.00

0.0

1.3

—

11.17

—

Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx, including Hilmo

0.00

-0.00

0.0

1.2

—

30.14

—

Accidental poisoning by and exposure to pesticides

0.00

-0.00

0.0

1.0

—

26.20

—

Acquired atrophy of ovary and fallopian tube

0.00

-0.00

0.0

1.2

—

27.33

—

Endometriosis in cutaneous scar

0.00

-0.00

0.0

1.0

—

26.17

—

Other congenital malformations, not elsewhere classified

0.00

-0.00

0.0

1.0

—

17.53

—

Contact with hot air and gases

0.00

-0.00

0.0

1.3

—

8.46

—

Radiodermatitis

0.00

-0.00

0.0

1.2

—

12.60

—

Ulcer of oesophagus, drug-induced

0.00

-0.00

0.0

1.4

—

26.20

—

Malignant neoplasm of gallbladder

0.00

-0.00

0.0

1.4

—

30.34

—

Drowning and submersion while in natural water

0.00

-0.00

0.0

1.2

—

56.89

—

Congenital nasolacrimal duct obstruction or stenosis, including avohilmo

0.00

-0.00

0.0

1.2

—

20.83

—

Magnesium deficiency

0.00

-0.00

0.0

1.3

—

10.43

—

Congenital ptosis

0.00

-0.00

0.0

1.0

—

22.80

—

Other congenital malformations of male genital organs, including avohilmo

0.00

-0.00

0.0

1.1

—

5.39

—

Malignant neoplasm of palate

0.00

-0.00

0.0

1.1

—

35.59

—

Malignant neoplasm of gum

0.00

-0.00

0.0

1.1

—

40.96

—

Other parasitologically confirmed or unspecified malaria, including avohilmo

0.00

-0.00

0.0

1.1

—

6.10

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

0.00

-0.00

0.0

1.3

—

6.45

—

Other hypertrichosis

0.00

-0.00

0.0

1.2

—

64.40

—

Toxic effect of organic solvents

0.00

-0.00

0.0

1.0

—

16.00

—

Poikiloderma of Civatte

0.00

-0.00

0.0

1.2

—

49.14

—

Non-small cell lung cancer, squamous

0.95

-0.00

1.3

1.1

16.43

30.87

u/l

—

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

0.00

-0.00

0.0

1.1

—

12.00

—

Restrictive cardiomyopathy

0.00

-0.00

0.0

1.2

—

50.95

—

Prominent ears

0.00

-0.00

0.0

1.0

—

7.44

—

Syndactyly, including avohilmo

0.00

-0.00

0.0

1.3

—

10.86

—

Thyrotoxicosis factitia

0.00

-0.00

0.0

1.1

—

19.25

—

Acute hepatitis B

0.00

-0.00

0.0

1.0

—

8.34

—

Schistosomiasis [bilharziasis], including avohilmo

0.00

-0.00

0.0

1.2

—

21.60

—

Foreign body granuloma of skin and subcutaneous tissue

0.00

-0.00

0.0

1.3

—

29.14

—

Benign neoplasm: Scrotum

0.00

-0.00

0.0

1.2

—

25.40

—

Secondary parkinsonism+Parkinsonism in other disease

0.91

-0.00

1.4

1.2

29.20

30.81

u/l

—

Pediculosis and phthiriasis

0.00

-0.00

0.0

1.2

—

16.95

—

Other sex chromosome abnormalities, male phenotype, not elsewhere classified

0.00

-0.00

0.0

1.0

—

9.39

—

Acquired keratosis [keratoderma] palmaris et plantaris

0.00

-0.00

0.0

1.2

—

12.60

—

Carcinoma in situ of oral cavity

0.00

-0.00

0.0

1.2

—

45.00

—

ICD 8 haemorrhage (epidural, subarachnoid, subduralis)

0.00

-0.00

0.0

1.2

—

65.80

—

Female pelvic inflammatory disorders in diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

8.80

—

Ankylosis of teeth

0.00

-0.00

0.0

1.1

—

39.43

—

Other cestode infections, including avohilmo

0.00

-0.00

0.0

1.4

—

22.29

—

Congenital malformations of spine and bony thorax

0.00

-0.00

0.0

1.1

—

25.14

—

Other and unspecified syphilis, including avohilmo

0.00

-0.00

0.0

1.2

—

8.14

—

Tooth agenesis EXCLUDE clefts and syndromes

0.92

-0.00

1.2

1.1

23.20

23.14

u/l

—

Acne keloid

0.00

-0.00

0.0

1.2

—

26.17

—

Benign neoplasm: Epididymis

0.00

-0.00

0.0

1.2

—

25.94

—

Other cestode infections

0.00

-0.00

0.0

1.5

—

22.50

—

Constitutional tall stature

0.00

-0.00

0.0

1.0

—

4.67

—

Chylothorax

0.00

-0.00

0.0

1.3

—

17.45

—

Chromomycosis and phaeomycotic abscess, including avohilmo

0.00

-0.00

0.0

1.2

—

6.60

—

Esophageal diverticulum (pouch), including avohilmo

0.00

-0.00

0.0

1.4

—

83.60

—

Non-seminoma of testis, including Hilmo

0.00

-0.00

0.0

1.0

—

36.94

—

Turner's syndrome

0.00

-0.00

0.0

1.0

—

7.74

—

Maternal care for (suspected) damage to fetus from alcohol

0.00

-0.00

0.0

1.6

—

72.00

—

Drug-induced dystonia

0.00

-0.00

0.0

1.4

—

11.14

—

Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced

0.00

-0.00

0.0

1.2

—

58.14

—

Effects of air pressure and water pressure

0.00

-0.00

0.0

1.2

—

16.20

—

Alcoholic cardiomyopathy

0.00

-0.00

0.0

1.1

—

33.09

—

Benign neoplasm: Heart

0.00

-0.00

0.0

1.3

—

48.17

—

Other and unspecified neuropathies

0.00

-0.00

0.0

1.3

—

40.33

—

Toxic effect of other noxious substances eaten as food

0.00

-0.00

0.0

1.2

—

21.12

—

Undescended testis, unilateral

0.00

-0.00

0.0

1.1

—

19.00

—

Acute hepatitis B, including avohilmo

0.00

-0.00

0.0

1.2

—

8.62

—

Defect, injury or illness of lumbar spine

0.00

-0.00

0.0

1.2

—

12.33

—

Other congenital malformations of male genital organs

0.00

-0.00

0.0

1.1

—

5.39

—

Histrionic personality disorder

0.00

-0.00

0.0

1.4

—

32.00

—

Benign neoplasm: Connective and other soft tissue of abdomen

0.00

-0.00

0.0

1.4

—

29.20

—

Open bite

0.99

-0.00

1.0

1.2

17.22

20.59

u/l

—

Mandibular prognathia AND surgery (LeFortI or BSSO)

0.00

-0.00

0.0

1.1

—

8.86

—

Maxillary hypoplasia

0.00

-0.00

0.0

1.2

—

4.34

—

Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced

0.00

-0.00

0.0

1.3

—

24.95

—

Sleepwalking [somnambulism]

0.00

-0.00

0.0

1.3

—

16.81

—

Maze procedure for atrial fibrillation

0.00

-0.00

0.0

1.3

—

61.86

—

Ectopic testis

0.00

-0.00

0.0

1.0

—

2.74

—

Pedestrian injured in collision with heavy transport vehicle or bus

0.00

-0.00

0.0

1.2

—

28.33

—

Palatinal maxillary canine

0.00

-0.00

0.0

1.0

—

4.44

—

Disorders of pituitary gland, other and/or unspecified

0.00

-0.00

0.0

1.2

—

7.86

—

Senile degeneration of the brain, not elsewhere classified

0.00

-0.00

0.0

1.2

—

44.00

—

Other and unspecified water transport accidents

0.00

-0.00

0.0

1.2

—

33.94

—

Defect, injury or illness of neck

0.00

-0.00

0.0

1.1

—

19.50

—

Other specified acquired deformities of limbs

0.00

-0.00

0.0

1.0

—

6.33

—

Cleft hard palate NOS

0.00

-0.00

0.0

1.2

—

15.80

—

Benign neoplasm: Testis

0.00

-0.00

0.0

1.2

—

51.78

—

Congenital ptosis, including avohilmo

0.00

-0.00

0.0

1.0

—

22.80

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS